lomefloxacin has been researched along with carbostyril in 368 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 52 (14.13) | 18.7374 |
| 1990's | 232 (63.04) | 18.2507 |
| 2000's | 80 (21.74) | 29.6817 |
| 2010's | 3 (0.82) | 24.3611 |
| 2020's | 1 (0.27) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, M; Daimon, Y; Furuta, T; Honda, M; Kanno, H; Kubo, S; Oguri, T; Satoh, K; Sugawara, K; Yamanaka, K | 1 |
| Berger, NS; Crawford, ED; Davis, MA; Donohue, RE | 1 |
| Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Pfaller, MA; Washington, JA | 1 |
| Jones, RN | 4 |
| Albera, C; Grassi, C; Pozzi, E | 1 |
| Ellison, WT; Gotfried, MH | 1 |
| Charton, M; Gattegno, B; Mombet, A | 1 |
| Childs, SJ; Klimberg, IW; Klimberg, SR; Madore, RJ | 1 |
| Bruce-Jones, P; Crome, P | 1 |
| Rizk, E | 1 |
| Maderazo, EG; Nightingale, CH; On, A; Pasternak, HS; Quintiliani, R; Sweeney, KR | 1 |
| Blum, RA | 1 |
| Mant, TG | 1 |
| Goss, TF; Schentag, JJ | 1 |
| Marstein, S; Nilsen, OG; Saltvedt, E; Walstad, RA | 1 |
| Benhamou, JP; Gaudin, C; Lebrec, D | 1 |
| Debbia, EA; Pesce, A; Schito, GC | 1 |
| García, I; Pascual, A; Perea, EJ | 2 |
| Ellal, JA; Mayer, KH | 1 |
| Aguirre-Avalos, G; Andrade-Villanueva, J; Flores-Gaxiola, A; Lopez-Guillen, P; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
| Iravani, A | 1 |
| Bergogne-Bérézin, E; Kafé, H; Muller-Serieys, C | 1 |
| Cox, CE | 1 |
| Ajana, F; Capron, MH; Chidiac, C; Home, P; Masquelier, AM; Mouton, Y | 1 |
| Kemper, P; Köhler, D | 1 |
| Hannan, A | 1 |
| Erwin, ME; Jones, RN | 1 |
| Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
| Kurumaji, Y; Shono, M | 1 |
| Nix, DE; Symonds, WT | 1 |
| Banerjee, DK; Ford, J; Markanday, S | 1 |
| Kitagawa, T; Miwa, H; Nishikawa, T; Oguma, T; Okabayashi, Y; Shiba, K; Shimada, J; Yamamoto, S; Yoshimura, Y | 1 |
| Adler, LP; Bednarczyk, EM; Berridge, MS; Green, JA; Leisure, GP; Little, D; Miraldi, FD; Nelson, AD; Panacek, EA | 1 |
| Bornigia, S; De Sio, G; Morbiducci, V; Piersimoni, C; Scalise, G | 1 |
| Kimura, M; Kobashi, Y; Matsushima, T; Nakamura, J | 1 |
| Glerum, JH; Hoepelman, AI; Kovarik, JM; Rozenberg-Arska, M; Sips, PA; Smit, JM; Verhoef, J | 1 |
| Gelber, RH; Iranmanesh, A; Murray, L; Siu, P; Tsang, M | 1 |
| Corrales, I; Mato, R; Prieto, J | 1 |
| Bartlett, RC; Mazens-Sullivan, MF; McCarter, YS | 1 |
| Capron, MH; Guibert, J | 1 |
| Forsgren, A; Hansson, C; Neringer, R; Ode, B | 1 |
| Fillastre, JP; Grise, P; Humbert, G; Leroy, A | 1 |
| Hashmi, ZS; Smith, JM | 4 |
| al-Shammary, FJ; el-Houfy, S; Shibl, AM; Tawfik, AF | 1 |
| Matsumoto, F; Soejima, R | 1 |
| Cowling, P; Lovering, AM; MacGowan, AP; McMullin, CM; Reeves, DS; Rogers, S; White, LO | 1 |
| Sato, H; Simanjuntak, MT; Tamai, I; Terasaki, T; Tsuji, A | 1 |
| Andrews, JM; Baldwin, DR; Honeybourne, D; Wise, R | 1 |
| Conejo, MC; García, I; Pascual, A; Perea, EJ | 1 |
| Barry, AL; Fuchs, PC | 2 |
| Pattyn, SR | 1 |
| Goa, KL; Wadworth, AN | 1 |
| Begg, EJ; Boswell, DR; Chambers, ST; Peddie, BA; Robson, RA | 1 |
| Dhib, M; Fillastre, JP; Grise, P; Leroy, A; Valtchev, B | 1 |
| Leigh, DA; Tait, S; Walsh, B | 1 |
| Hancock, P; Harris, C; Leigh, DA; Tait, S; Walsh, B | 1 |
| Ellis, ME; Lee, GC; Qadri, SM | 1 |
| Cartwright, FD; Kenny, GE | 1 |
| Kamisaka, K; Kawahara, S; Kibata, M; Matsuyama, T; Mishima, Y; Nagare, J; Nakada, H; Tada, A; Yoshimoto, S | 1 |
| Bébéar, C; Renaudin, H | 1 |
| Apichartpichean, R; Hasegawa, T; Kuzuya, T; Miyamoto, K; Muraoka, I; Nadai, M; Takagi, K | 1 |
| Healy, DP; Polk, RE; Schoenle, JR; Stotka, J | 1 |
| Blum, RA; Schentag, JJ; Schultz, RW | 1 |
| Boon, T; de Hond, JA; Hoepelman, IM; Kovarik, JM; Verhoef, J | 1 |
| Igual, A; Jauch, A; Nos-Barbéra, S; Portolés, M | 1 |
| McDonald, PJ; Pruul, H | 1 |
| Chimura, T; Saito, H | 1 |
| Rustige, C; Wiedemann, B | 1 |
| Allen, RA; Amyes, SG; Lewin, CS | 1 |
| Gohro, T; Hayashi, K; Henmi, I; Kato, S; Kumamoto, Y; Sakai, S; Tabata, S; Tanda, H; Tsunekawa, T; Yoshio, H | 1 |
| Abe, K; Gohro, T; Hayashi, K; Hirose, T; Kodama, N; Kumamoto, Y; Miyagishi, T; Mohri, K; Ueno, T | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Hall, MC; Piddock, LJ; Wise, R | 1 |
| Butler, T; Cartagenova, M; Dunn, D | 1 |
| Acar, JF; Chanal, M; Dabernat, H; Drugeon, H; Fleurette, J; Le Van Thoi, J; Morel, C; Soussy, CJ; Thabaut, A; Vallée, E | 1 |
| Cornel, JH; Martea, M; Vree, TB; Wijnands, GJ | 1 |
| Dickinson, RG; Eadie, MJ; Hooper, WD | 1 |
| Manuĭlov, KK | 1 |
| Brismar, B; Edlund, C; Nord, CE | 1 |
| Carbon, C; Gros, I | 1 |
| Fillastre, JP; Humbert, G; Leroy, A | 1 |
| Atkinson, HC; Begg, EJ; Frampton, CM; Robson, RA; Saunders, DA | 1 |
| Kawamura, N; Kawashima, T; Koinuma, A; Nishizawa, K; Ohhara, K | 1 |
| Matsumoto, F; Morita, M; Takahashi, T | 1 |
| Kashina, LB; Manuĭlov, KK | 1 |
| Andrews, JM; Ashby, JP; Baldwin, DR; Honeybourne, D; Wise, R | 1 |
| LeBel, M; St-Laurent, M; Vallée, F | 1 |
| Bhattacharya, SS; Lal, HM; Lalitha, MK; Nisha, AK; Ramamoorthy, U | 1 |
| Hase, T; Kato, H; Koikeda, S; Masamune, Y; Nakanishi, N; Okabe, H; Okezaki, E; Shibata, H | 1 |
| Fukuda, M; Sasaki, K | 2 |
| Glupczynski, Y; Grenier, P; Pierard, D; Van der Auwera, P | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Andrews, JM; Ashby, JP; Kavi, J; Stone, J; Wise, R | 1 |
| Amyes, SG; Lewin, CS; Smith, JT | 1 |
| Greenwood, D; Kanematsu, M | 1 |
| Acar, JF; Bellanger, B; Guibert, J; Kitzis, MD; Masquelier, AM | 1 |
| Courvalin, P; Derlot, E; Poyart-Salmeron, C | 1 |
| Romanowski, B; Talbot, H | 1 |
| Apichartpichean, R; Hasegawa, T; Kuzuya, T; Muraoka, I; Nadai, M; Takagi, K | 1 |
| Amano, M; Arakawa, S; Fujita, Y; Ishigami, J; Kamidono, S; Kanemasa, Y; Kumon, H; Ohmori, H; Suzuki, K; Tanaka, H | 1 |
| Nix, DE; Norman, A; Schentag, JJ | 1 |
| Aoki, T; Kanehisa, N; Matsubara, Y; Murata, M; Nitta, Y; Sagara, H; Seo, T; Shimizu, N; Takizawa, Y; Tomizawa, I | 1 |
| Peddie, BA | 1 |
| Hayata, S; Kishi, M; Kumon, H; Mizuno, A; Nanba, K; Nasu, Y; Nishitani, Y; Ohmori, H; Tsugawa, M; Yamada, D | 1 |
| Fuhr, U; Harder, S; Staib, AH; Wack, C | 1 |
| Kato, H; Nagata, O; Nakamura, M; Okezaki, E; Terasaki, T; Tsuji, A | 1 |
| Kunii, O; Ono, Y | 1 |
| Canepari, P; Cornaglia, G; Fontana, R; Ligozzi, M; Pelosi, E | 1 |
| Goodman, LJ; Kaplan, RL; Nelson, JA; Segreti, J; Trenholme, GM | 1 |
| Dette, GA; Knothe, H | 1 |
| Arakawa, S; Fujii, A; Kamidono, S; Maeda, H; Nakata, K | 1 |
| Weinstein, MP | 1 |
| Aldridge, KE; Barry, AL; Fuchs, PC; Gerlach, EH; Jones, RN; Pfaller, MA; Washington, JA | 1 |
| Andrews, JM; Ashby, JP; Matthews, RS; Wise, R | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Nagayama, A; Nakao, T; Taen, H | 1 |
| Chin, NX; Neu, HC; Novelli, A | 1 |
| Kato, H; Nagata, O; Okezaki, E; Sato, H; Tsuji, A; Yamamoto, S | 1 |
| Andrews, JM; Ashby, JP; Griggs, D; Stone, JW; Wise, R | 1 |
| Dohtsu, Y; Hara, K; Hayashi, T; Hirota, M; Koga, H; Kohno, S; Saito, A; Yamaguchi, K | 1 |
| Higgins, C; McAnulty, PA; Tesh, JM; Tesh, SA; Wilby, OK; Willoughby, CR | 2 |
| McAnulty, PA; Tesh, JM; Tesh, SA; Wilby, OK; Willoughby, CR | 1 |
| Kunka, RL; Mant, TG; Morrison, PJ; Norman, GT; Robinson, J | 1 |
| Nishino, T; Obana, Y | 1 |
| Ikejiri, Y; Kuriyama, H; Miyao, M; Ooishi, M; Oomomo, A; Sakaue, F; Sameshima, S; Tazawa, H | 1 |
| Finch, R; Martin, J; Pilkington, R | 1 |
| Edwards, R; Greenwood, D; Kanematsu, M | 1 |
| Aoki, Y; Kasano, Y; Kitamura, T; Mukaihara, S; Nakai, T; Tamura, K; Tanimura, H; Terao, R; Uesaka, K; Yotsumoto, F | 1 |
| Ito, Y; Nagata, O; Okezaki, E; Saito, A; Takahara, Y; Yamada, T | 1 |
| Hirose, T; Inoue, M; Ito, Y; Kato, H; Mitsuhashi, S; Okezaki, E | 1 |
| Costa, FJ | 1 |
| Cormican, MG; Jones, RN | 1 |
| Kitade, M; Moritaka, T; Nakanishi, N; Ueda, N | 1 |
| Dvoretskiĭ, LI; Iakovlev, SV; Izotova, GN; Kolendo, SE; Miagkov, AV; Shvyreva, GS; Vorob'ev, PA | 1 |
| Koeppe, P; Lode, H; Rost, KL; Schaberg, T; Stuht, H | 1 |
| Hatakeyama, T; Morita, M; Suzuki, K | 1 |
| Aoki, M; Hirose, T; Kumamoto, Y; Miyake, M; Sakai, S; Shibuya, A; Shimamura, S; Takatsuka, K; Umehara, T; Yamazaki, K | 2 |
| Feinberg, SS | 1 |
| Beskid, G; Prosser, BL | 2 |
| Blatun, LA; Grishina, IA; Iakovlev, VP; Svetukhin, AM | 1 |
| Davidson, RJ; Drobot, GR; Hoban, DJ; Karlowsky, JA; Philips, R; Zhanel, GG | 1 |
| el-Kersh, TA; Ramadan, MA; Shibl, AM; Tawfik, AF | 1 |
| D'iakov, SI; Katsalukha, VV; Lebedeva, IK; Lukashina, AV; Raĭskaia, VA | 1 |
| Erwin, ME; Jones, RN; Sader, HS | 1 |
| Fujita, H; Matsuo, I | 1 |
| Arditi, MR; Drago, F; Rebora, A | 1 |
| Kudo, M; Ohkubo, T; Sawada, Y; Sugawara, K | 1 |
| Kivistö, KT; Lehto, P | 1 |
| Bourget, T; Fakouhi, TD; Lowe, NJ; Roniker, B; Stern, RS; Swabb, EA | 1 |
| De Francesco, M; Longo, M; Pizzi, R; Pollara, P; Ravizzola, G | 1 |
| Barros, MA; Correia, O; Delgado, L | 1 |
| Dutov, VV; Kalinin, VN; Nasonov, VN; Nekhorosheva, AG; Rusanova, EV; Savitskaia, KI; Shanina, AG; Solodilova, OE; Trapeznikova, MF | 1 |
| Ebihara, A; Fujimura, A; Harada, K; Ohashi, K; Sasaki, M; Shiga, T; Sudoh, T; Tateishi, T | 1 |
| Dubois, J; Harding, GK; Louie, TJ; Martel, A; Nicolle, LE; Sinave, CP | 1 |
| Hatano, H; Inoue, K; Liping, W; Shia, S | 1 |
| Akimoto, Y; Fujii, A; Kaneko, K; Kawana, T; Komiya, M; Mochizuki, Y; Nishimura, H; Omata, H; Shibutani, J; Uda, A | 1 |
| Diao, Y; Tan, L; Xu, DK; Yuan, YS | 1 |
| Honma, H; Kang, K; Tozawa, K; Washida, H; Yamada, Y | 1 |
| Cantón, E; Gobernado, M; Jiménez, T; Pemán, J; Ramón, MS | 1 |
| Croizé, J; Le Noc, D; Le Noc, P | 1 |
| Diao, Y; Ji, G; Li, L; Lu, J; Wang, EH; Zhu, XD | 1 |
| Belliveau, P; Crowe, H; Gousee, G; Nightingale, CH; Quintiliani, R | 1 |
| Gage, TW | 1 |
| Andrews, JM; Baldwin, DR; Gill, M; Honeybourne, D; Wise, R | 1 |
| Poh-Fitzpatrick, MB | 1 |
| Nunome, M; Takahata, M; Yamashiro, Y; Yasuda, T | 1 |
| Hasegawa, Y; Ichiyama, S; Ikeda, T; Nakanishi, K; Nishiwaki, K; Saka, H; Shimokata, K; Taniguchi, K; Totani, Y; Yamada, Y | 1 |
| Drusano, GL; Johnson, DE; Rosen, M; Standiford, HC | 1 |
| Conly, JM; DuBois, J; Harding, GK; Martel, AY; Nicolle, LE; Shafran, SD | 1 |
| Riley, CM; Ross, DL; Takusagawa, F; Vander Velde, D | 1 |
| Mochizuki, K; Sakai, H; Torisaki, M | 1 |
| Belliveau, PP; Freeman, CD; Nicolau, DP; Nightingale, CH | 1 |
| Benne, RA; Boon, TA; de Hond, HA; de Wit, MA; Havinga, WH; Hoepelman, IM; van Asbeck, FW; Verhoef, J; Visser, MR; Zwinkels, M | 1 |
| Ismaeel, NA; Tayeb, OS | 1 |
| Spivey, IM | 1 |
| Ellis-Pegler, RB; Hyman, LK; Ingram, RJ; McCarthy, M | 1 |
| Knaub, SR; Morton, MD; Priston, MJ; Riley, CM; Slechta, JD; Vander Velde, DG | 1 |
| Carr, RA; Foster, RT; Longstreth, JA; Pasutto, FM | 1 |
| Hale, JA; Knapp, JS; Neal, SW; Rice, RJ; Whittington, WL; Wintersheid, K | 1 |
| Angrisani, M; Cazzola, M; Contaldi, C; Loffreda, A; Losasso, C; Rossi, F | 1 |
| Fakouhi, TD; Harrison, GI; Hawk, JL; Roniker, B; Swabb, EA; Young, AR | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Iakovlev, SV; Iakovlev, VP; Izotova, GN | 1 |
| Cormican, MG; Erwin, MS; Jones, RN | 1 |
| Cheung, MM; Ho, NK; Kam, KM; Wong, PW | 1 |
| Fukuda, S; Inatomi, M; Kanda, Y; Kiuchi, Y; Koide, R; Oguchi, K; Sato, H; Uchida, N | 1 |
| Iordanova, AI; Nikitin, AV | 1 |
| Bartoletti, R; Pisani, E; Rizzo, M; Trinchieri, A | 1 |
| Jauch, A; Kari, O; Latvala, ML; Malminiemi, K; Miettinen, A; Voutilainen, R | 1 |
| Chang, MF; Knaub, SR; Lunte, CE; Riley, CM; Topp, EM | 1 |
| Fujimura, A; Sasaki, M | 1 |
| Fujimura, A; Harada, K; Ohmori, M; Sakamoto, K; Sudoh, T; Sunaga, K | 1 |
| Albertini, S; Chételat, AA; Gocke, E | 1 |
| Abalain, ML; Colin, J; Jauch, A; Malet, F | 1 |
| DeJesus, OJ; Frank, P; Macy, D; Nickles, RJ; Perlman, SB; Taylor, M; Tewson, TJ; Wong, G; Yang, D | 1 |
| Capron, MH; Giacomino, A; Guibert, J | 1 |
| Gracheva, MP; Mozhokina, GN; Sokolova, GB | 1 |
| Iordanova, AI; Navashin, PS; Nikitin, AV; Smolkina, TV | 1 |
| Kunichan, AD; Mozhokina, GN; Shapatava, MN | 1 |
| Makarova, OV; Mikhaĭlova, LP; Mozhokina, GN; Sokolova, GB | 1 |
| Ballesta, S; García, I; Pascual, A; Perea, EJ | 1 |
| Capron, MH; Guibert, J; Herman, H | 1 |
| Amano, H; Fukuhara, S; Kanachi, K; Kawasaki, T; Ohno, T; Okuma, M; Sasada, M; Suzuki, T; Yasuda, N; Yumoto, Y | 1 |
| Chignell, CF; Li, G; Martinez, LJ | 1 |
| Klecak, G; Urbach, F; Urwyler, H | 1 |
| Forbes, PD; Mäkinen, M; Stenbäck, F | 1 |
| Anan'eva, LP; Belov, BS; Nasonova, VA; Shubin, SV; Soldatova, SI; Tarasova, GM; Urumova, MM; Ushakova, MA | 1 |
| Astorri, AL; Margariti, PA; Mastromarino, C | 1 |
| Kunichian, AD; Mozhokina, GN; Shapatava, MN; Sokolova, GB | 1 |
| Arakane, K; Hirobe, M; Mashiko, S; Nagano, T; Ryu, A; Umezawa, N | 1 |
| Chen, D; Prahalad, AK; Rosen, JE; Schlüter, G; Williams, GM | 1 |
| Irikov, OA; Romanov, IuA | 1 |
| Johnson, NJ; Kluwe, WM; Lencoski, DL; Mayne, JT; Polzer, RJ | 1 |
| Filippovich, SS; Irikov, OA; Romanov, IuA | 1 |
| Choi, EC; Kang, JA; Kim, BK; Kim, JH; Kim, JW; Kim, YG; Lee, JH | 1 |
| Klinberg, NM; Mar'iandyshev, AO; Moroz, MI; Shonbina, AI | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Herbert, D; Kamala, T; Paramasivan, CN; Venkatesan, P | 1 |
| Rosen, JE | 1 |
| Elena, PP; Jauch, A | 1 |
| Choi, EC; Choi, KH; Kim, BK; Kim, JH; Kim, JW; Lee, JH | 1 |
| Kawada, A; Kimura, M | 1 |
| Iakovlev, VP; Padeĭskaia, EN | 1 |
| Kuznetsovoĭ, SM | 1 |
| Callery-D'Amico, S; Cox, CE; Fowler, CL; Kim, SS; King, W; Klimberg, IW | 1 |
| Cui, H; Hou, J; Li, J | 1 |
| Kato, M; Shimoda, K | 1 |
| Chen, D; Schluter, G; Verna, LK; Williams, GM | 1 |
| Baumann-Wilschke, I; Förster, C; Rücker, M; Shakibaei, M; Stahlmann, R; Vormann, J | 1 |
| Ahmad, N; Habib, F; Hafiz, S; Haq, I; Husain, R | 1 |
| Chignell, CF; Martínez, L | 1 |
| Padeĭskaia, EN | 2 |
| Koriakin, VA; Kunichan, AD; Lazareva, IaV; Sokolova, GB | 1 |
| Kunichan, AD; Levchenko, TN; Mozhokina, GN; Smirnova, NS | 1 |
| Grishin, VK; Polunina, TE | 1 |
| Belousov, IuB; Efremenkova, OV; Komarova, VP | 1 |
| Bykova, AV; Emel'ianov, AV; Fedoseev, GB; Rudinskiĭ, KA; Shevelev, SE | 1 |
| Alekseev, AA; Bobrovnikov, AE; Elagina, LV; Grishina, IA; Iakovlev, VP; Izotova, GN; Krutikov, MG | 1 |
| Kononenko, LA; Maĭchuk, IuF; Vakhova, ES | 1 |
| Andriukhin, MI; Avdoshin, VL; Derevianko, II; Gabliia, MIu; Khodyreva, LA | 1 |
| Iakovlev, SV | 1 |
| Iakovlev, VP | 1 |
| Albini, A; Fasani, E; Profumo, A | 1 |
| Arata, J; Horio, T; Ohara, K; Soejima, R | 1 |
| Anjo, S; Hara, A; Nakamura, M; Sakai, M | 1 |
| Kato, Y; Sasabe, H; Sugiyama, Y; Terasaki, T; Tsuji, A | 1 |
| Ferguson, J; Man, I; Murphy, J | 1 |
| Bonini, S; Bonomi, L; Bucci, MG; Bujtar, E; Colangelo, L; Curatola, MR; Damiani, S; Della Loggia, G; Gallenga, PE; Jauch, A; Lobefalo, L; Milan, E; Orzalesi, N; Pagliarusco, A; Palma, LA; Ponte, F; Tomazzoli Gerosa, L; Velati, P | 1 |
| Fsadni, M; Gamba, G; Jauch, A | 1 |
| Fukuda, M; Sasaki, K; Yoshitake, Y | 1 |
| Brashear, RL; Flanagan, DR; Kemper, MS; Luner, PE; Seyer, JJ | 1 |
| Jiménez de Anta, MT; Martín-Sánchez, AM; Ruiz, J; Tavío, MM; Vila, J | 1 |
| El'kun, GB | 1 |
| Gomi, H; Hatanaka, K; Kawada, A; Matsuo, I | 1 |
| Greenberg, RN; Newman, MT; Pectol, RW; Shariaty, S | 1 |
| Agarwal, HC; Biswas, NR; Gupta, SK; Gupta, YK; Velpandian, T | 1 |
| Gibbs, NK; Traynor, NJ | 1 |
| Belousov, IuB; Efremenkova, OV; Sokolov, AV; Tishenkova, IF | 1 |
| Martynova, LP; Mishin, VIu; Vasil'eva, IA | 1 |
| Al-Ajmi, H; Colman, PJ; Ferguson, J; McEwen, J; Purkins, L; Willavize, SA | 1 |
| Agapakis-Causse, C; Marrot, L | 1 |
| Figueiredo, AC; Gonçalo, M; Oliveira, HS | 1 |
| Bubnov, VP; D'iakov, SI; Lebedeva, IK; Moskalenko, VI; Sidorenko, SV | 1 |
| Ellis-Pegler, RB; Voss, LM | 1 |
| Ikeda, T; Kato, M; Okawara, S; Shimoda, K | 1 |
| Al-Bella, S; Al-Khamis, KI; Al-Rashood, KA; Al-Yamani, MA; Alam, SM; Dham, R; El-Sayed, YM | 1 |
| Hiraku, Y; Kawanishi, S | 2 |
| Elistratova, NA; Kunichan, AD; Mozhokina, GN; Perel'man, MI; Sokolova, GB | 1 |
| Drusano, GL | 1 |
| Deka, PM; Rajeev, TP | 1 |
| Leitão, ML; Redinha, JS; Teixeira, F; Teixeira, MH | 1 |
| Castell, JV; Morlière, P; Ouédraogo, G; Santus, R | 1 |
| Agapakis-Causse, C; Gibbs, NK; Kidd, S; Marrot, L; Meunier, JR; Traynor, NJ | 1 |
| Ahr, HJ; Blotz, A; Blümel, J; Dubertret, L; Michel, L; Moysan, A; Vohr, HW | 1 |
| de Vries, H; van Henegouwen, GM | 1 |
| Dominici, A; Nerozzi, S; Novelli, A; Ponchietti, R; Rizzo, M; Scelzi, S; Travaglini, F | 1 |
| Agapakis-Causse, C; Belaidi, JP; Chaubo, C; Marrot, L; Meunier, JR; Perez, P | 1 |
| Gordon, YJ; Kowalski, RP; Romanowski, EG; Yates, KA | 1 |
| Gonçalves, NJ; Maya, MT; Morais, JA; Silva, NB | 1 |
| Albini, A; Fasani, E; Monti, S; Sortino, S | 1 |
| Araujo, L; Navalón, A; Prieto, A; Vílchez, JL | 1 |
| Cantoni, V; Catalanotti, P; Cazzola, M; Fici, F; Matera, MG; Polverino, M; Rossi, F; Sarlo, F; Tufano, MA | 1 |
| Bai, ZZ; Guan, DW; Zhang, QS | 1 |
| Iwatsu, M; Kanai, A; Tian, X | 1 |
| Iwatsu, M; Kanai, A; Sado, K; Tian, X | 1 |
| Jiang, S; Wang, R; Zhao, M | 1 |
| Cantoni, V; Melani, AS; Pirrelli, M; Sarlo, F | 1 |
| Baumann-Wilschke, I; Rücker, M; Shakibaei, M; Stahlmann, R | 1 |
| Chen, Y; Chen, Z; Zhang, Y | 1 |
| Feng, P; Lei, B; Lu, X; Xia, P; Zhong, L | 1 |
| Guo, W; Shao, Y; Song, JF | 1 |
| Schaeffer, AJ | 1 |
| Naber, KG | 2 |
| Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
| Fukuda, H; Kawamura, Y | 1 |
| Furuhama, K; Itoh, S; Katoh, M | 1 |
| Patel, DB; Rathod, IS; Savale, SS; Shah, SA | 1 |
| Jin, LP; Lu, Y; Ma, HM; Nie, LH; Wang, X; Yi, L; Zhao, HC | 1 |
| Jha, AM; Kumar, M; Singh, AC | 1 |
| Bai, ZZ; Sheng, LS; Zhang, QS | 1 |
| Monti, S; Sortino, S | 1 |
| Li, JL; Ma, XC; Tu, ZH; Xin, J; Zhang, T | 2 |
| Wos, M; Zünkler, BJ | 1 |
| Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY | 1 |
| Chignell, CF; Haseman, JK; Sik, RH; Tennant, RW; Trempus, CS | 1 |
| Belaïdi, JP; Jones, C; Marrot, L; Meunier, JR; Perez, P; Riou, L; Sarasin, A | 1 |
| Du, LM; Wang, JP; Xu, QQ | 1 |
| Ono, C; Tanaka, M | 1 |
| Kawai, M; Mashima, Y; Mochizuki, H; Yamada, K; Yamada, M | 1 |
| Maĭchuk, IuF | 1 |
| Hong, JW; Hu, CQ; Sheng, LS | 1 |
| Booranapong, W; Kosrirukvongs, P; Prabhasawat, P; Srivannaboon, S; Suttiprakarn, P | 1 |
| Hatano, K | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Sato, Y; Watabe, E | 1 |
| Dashieva, DG; Elistratova, NA; Mikhaĭlova, LP; Mozhokina, GN; Sokolova, GB | 1 |
| Paramasivan, CN; Rahman, F; Sulochana, S | 1 |
| Abba, M; Donnelly, J; Hussain, B; Shervington, LA | 1 |
| Artemenko, N; Gorelov, A; Perekalina, T; Smelov, V; Smelova, N; Ukleeva, G | 1 |
| Erjongmanee, S; Kasetsuwan, N; Pariyakanok, L; Phusitphoykai, N; Puangsricharern, V | 1 |
| Kassab, NM; Kedor-Hackmam, ER; Santoro, MI; Singh, AK | 1 |
| Horio, T; Itoh, T; Miyauchi-Hashimoto, H; Sugihara, A; Tanaka, K | 1 |
| Abdel Ghani, NT; El Ries, MA; El-Shall, MA; Wassel, AA | 1 |
| Cocuzza, CE; Cocuzza, G; Mattina, R | 1 |
| Newsom, SW; Rowland, C | 1 |
| Caccamo, F; Mezzatesta, M; Nicoletti, G; Pellegrino, MB; Russo, G; Speciale, AM; Stefani, S | 1 |
| Rossolini, GM; Satta, G; Vaiani, G; Valentini, S | 1 |
| Azadian, BS; Roberts, AP; Talboys, CA | 1 |
| Carlone, NA; Cuffini, AM; Tullio, V; Vaiani, G | 1 |
| Liu, C; Lu, Q; She, S; Wang, L; Zhou, Y | 1 |
| Arayne, MS; Furqan, H; Sultana, N | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Jiang, C; Wang, H; Wei, W | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Ishikawa, K; Kawai, M; Mochizuki, H; Yamada, M | 1 |
| Hori, S; Kawamura, M; Kizu, J | 1 |
| Baeyens, WR; Ouyang, J; Yang, Y; Zhao, H; Zhou, S | 1 |
| Gross-Tholl, N; Herbold, B; von Keutz, E; Wirnitzer, U | 1 |
| Ni, YN; Zhang, GW | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
| Cybulski, M; Deslauriers, Y; Ferrarotto, C; Miller, SM; Reinhardt, P; Wilkins, R | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Baeyens, WR; Fei, G; He, L; Huang, C; Ouyang, J; Wang, Y | 1 |
| Carda-Broch, S; Esteve-Romero, J; Rambla-Alegre, M | 1 |
| Li, YW; Mo, CH; Su, QY; Tai, YP; Wang, JY; Wu, XL; Zhang, Y | 1 |
| Jiang, W; Korshin, GV; Liu, C; Nanaboina, V | 1 |
| Cai, QH; Chen, GH; Chen, P; Guo, X; Meng, HL; Tian, YF | 1 |
| Banach, K; Karkoszka, M; Kowalska, J; Rok, J; Rzepka, Z; Wrześniok, D | 1 |
22 review(s) available for lomefloxacin and carbostyril
| Article | Year |
|---|---|
Infection in the elderly: studies with lomefloxacin.
Topics: Aged; Aging; Anti-Infective Agents; Bacterial Infections; Bronchitis; Female; Fluoroquinolones; Humans; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Premedication; Quinolones; Randomized Controlled Trials as Topic; Urinary Tract Infections | 1992 |
The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Fluoroquinolones; Humans; Meta-Analysis as Topic; Premedication; Quinolones; Randomized Controlled Trials as Topic; United States; Urinary Tract Infections | 1992 |
Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
Topics: Anti-Infective Agents; Creatinine; Fluoroquinolones; Humans; Kidney Failure, Chronic; Meta-Analysis as Topic; Metabolic Clearance Rate; Quinolones | 1992 |
Quinolone pharmacokinetics in the elderly.
Topics: Aged; Aging; Anti-Infective Agents; Creatinine; Fluoroquinolones; Humans; Meta-Analysis as Topic; Metabolic Clearance Rate; Quinolones | 1992 |
Lomefloxacin: microbiologic assessment and unique properties.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Drug Resistance, Microbial; Fluoroquinolones; Meta-Analysis as Topic; Microbial Sensitivity Tests; Quinolones | 1992 |
Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Humans; Quinolones | 1992 |
[Review [new antimicrobial agent series XLI]: lomefloxacin].
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Fluoroquinolones; Humans; Mice; Quinolones; Rats; Tissue Distribution | 1991 |
Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Interactions; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones | 1991 |
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Drug Tolerance; Female; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Cocci; Humans; Male; Ofloxacin; Quinolones; Treatment Outcome | 1993 |
Lomefloxacin clinical pharmacokinetics.
Topics: Administration, Oral; Aging; Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluoroquinolones; Humans; Intestinal Absorption; Kidney; Liver; Quinolones; Tissue Distribution | 1993 |
[Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Pefloxacin; Quinolones; Renal Insufficiency | 1995 |
[Urinary tract infections: risk factors and therapeutic trends].
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Female; Fluoroquinolones; Humans; Male; Quinolones; Risk Factors; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1997 |
[The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
Topics: Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Tissue Distribution | 1998 |
[Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Legionellosis; Meningitis, Bacterial; Quinolones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
Topics: Age Factors; Anti-Infective Agents; Area Under Curve; Creatinine; Drug Interactions; Fluoroquinolones; Humans; Intestinal Absorption; Liver Diseases; Quinolones; Renal Insufficiency; Tissue Distribution | 1998 |
Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Child; Clinical Trials, Phase III as Topic; Conjunctivitis, Bacterial; Drug Administration Schedule; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Quinolones; Treatment Outcome | 1999 |
[A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia].
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Antitubercular Agents; Bacterial Infections; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Quinolones; Russia | 2000 |
Sequence-specific DNA damage induced by UVA radiation in the presence of endogenous and exogenous photosensitizers.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Carcinogens; Cell Transformation, Neoplastic; Deoxyguanosine; DNA; DNA Adducts; DNA Damage; Fluoroquinolones; Guanine; Humans; Models, Chemical; Mutagenesis; Nalidixic Acid; Neoplasms, Radiation-Induced; Oxidation-Reduction; Oxygen; Pteridines; Pterins; Quinolones; Radiation-Sensitizing Agents; Singlet Oxygen; Skin Neoplasms; Sunlight; Superoxides; Ultraviolet Rays | 2001 |
The expanding role of fluoroquinolones.
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Quinolones; Urinary Tract Infections | 2002 |
Levofloxacin in the treatment of urinary tract infections and prostatitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostatitis; Quinolones; Severity of Illness Index; Treatment Outcome; Urinary Tract Infections | 2004 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
71 trial(s) available for lomefloxacin and carbostyril
| Article | Year |
|---|---|
Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacteremia; Cefotaxime; Female; Female Urogenital Diseases; Fluoroquinolones; Humans; Injections; Male; Male Urogenital Diseases; Postoperative Complications; Premedication; Quinolones; Urethra; Urinary Tract Infections | 1992 |
Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic Disease; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Quinolones; Recurrence; Treatment Outcome | 1992 |
Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefaclor; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Recurrence; Single-Blind Method; Treatment Outcome | 1992 |
Urinary tract infection prophylaxis in transurethral surgery: oral lomefloxacin versus parenteral cefuroxime.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Cefuroxime; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Premedication; Prospective Studies; Quinolones; Urethra; Urinary Tract Infections; Urogenital System | 1992 |
A multicenter comparison of oral lomefloxacin versus parenteral cefotaxime as prophylactic agents in transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefotaxime; Female; Fluoroquinolones; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Premedication; Quinolones; Urethra; Urinary Tract Infections; Urogenital System | 1992 |
Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Infective Agents; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Administration Schedule; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Reference Values | 1992 |
Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Single-Blind Method; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1992 |
Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Norfloxacin; Quinolones; Single-Blind Method; Treatment Outcome; Urinary Tract Infections | 1992 |
Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Bronchi; Bronchoscopy; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones | 1992 |
A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Quinolones; Recurrence; Single-Blind Method; Treatment Outcome; Urinary Tract Infections | 1992 |
A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pyelonephritis; Quinolones; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Quinolones; Treatment Outcome | 1992 |
Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen metabolism in healthy subjects by positron emission tomography.
Topics: Adolescent; Adult; Anti-Infective Agents; Brain; Cerebrovascular Circulation; Ciprofloxacin; Female; Fluoroquinolones; Glucose; Humans; Male; Oxygen; Quinolones; Tomography, Emission-Computed | 1992 |
Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Administration Schedule; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1992 |
Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Quinolones; Sweden; Urinary Tract Infections | 1992 |
Lack of interaction between lomefloxacin and caffeine in normal volunteers.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Caffeine; Double-Blind Method; Drug Interactions; Fluoroquinolones; Half-Life; Humans; Male; Quinolones; Theophylline | 1991 |
[Epidemiological and therapeutic study on gonorrheal infection--study on NY-198 (lomefloxacin) single administration therapy. Sapporo Clinical Research Group for STD].
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Resistance, Microbial; Female; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Middle Aged; Neisseria gonorrhoeae; Quinolones; Urethritis; Uterine Cervicitis | 1990 |
[Epidemiological and therapeutic study on urethritis of male and cervicitis from viewpoint of STD--a study using NY-198. Sapporo Clinical Research Group for STD].
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Resistance, Microbial; Female; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Middle Aged; Neisseria gonorrhoeae; Quinolones; Sexually Transmitted Diseases; Urethritis; Uterine Cervicitis | 1990 |
[In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria, Anaerobic; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Multicenter Studies as Topic; Quinolones | 1990 |
Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days.
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Half-Life; Humans; Middle Aged; Quinolones; Reference Values | 1990 |
Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Male; Oxidation-Reduction; Quinolones; Random Allocation; Theophylline | 1990 |
[A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Child; Clinical Trials as Topic; Cystitis; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Quinolones; Recurrence | 1989 |
[Comparison of clinical efficacy of lomefloxacin (LFLX, NY-198) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Lomefloxacin Research Group Enteritis].
Topics: 4-Quinolones; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Double-Blind Method; Drug Evaluation; Enteritis; Female; Fluoroquinolones; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Nicotinic Acids; Pipemidic Acid; Quinolones | 1989 |
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mutation; Penicillins; Quinolones; Statistics as Topic; Tetracycline | 1988 |
Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Male; Quinolones | 1988 |
Lomefloxacin prophylaxis in visual laser ablation of the prostate.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacteriuria; Fluoroquinolones; Humans; Laser Therapy; Male; Middle Aged; Postoperative Complications; Premedication; Prostate; Prostatic Hyperplasia; Quinolones | 1994 |
Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Topics: Adult; Anti-Infective Agents; Biotransformation; Chromatography, High Pressure Liquid; Ciprofloxacin; Double-Blind Method; Drug Interactions; Female; Fluoroquinolones; Half-Life; Humans; Male; Omeprazole; Quinolones | 1995 |
[Clinical efficacy of lomefloxacin (100 mg or 300 mg) single-dose therapy in female acute uncomplicated cystitis].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Cystitis; Double-Blind Method; Female; Fluoroquinolones; Humans; Middle Aged; Quinolones | 1995 |
[Long-term monitoring of female acute uncomplicated cystitis cases after lomefloxacin single-dose therapy].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Humans; Middle Aged; Quinolones; Recurrence; Surveys and Questionnaires | 1995 |
Different effects of products containing metal ions on the absorption of lomefloxacin.
Topics: Absorption; Adult; Animals; Anti-Infective Agents; Biological Availability; Calcium Carbonate; Cross-Over Studies; Female; Ferrous Compounds; Fluoroquinolones; Humans; Male; Milk; Quinolones; Sucralfate | 1994 |
Photoreactions with a fluoroquinolone antimicrobial: evening versus morning dosing.
Topics: Adult; Anti-Infective Agents; Cross-Over Studies; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Photosensitivity Disorders; Quinolones; Time Factors | 1994 |
[Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Recurrence; Urinary Tract Infections | 1994 |
Renal clearance of lomefloxacin is decreased by furosemide.
Topics: Adult; Anti-Infective Agents; Chlorides; Double-Blind Method; Drug Interactions; Fluoroquinolones; Furosemide; Humans; Male; Potassium; Quinolones; Sodium; Urodynamics | 1994 |
Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Single-Blind Method; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1994 |
[A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteria; Female; Fluoroquinolones; Humans; Male; Middle Aged; Photosensitivity Disorders; Prospective Studies; Quinolones; Retrospective Studies; Urinary Tract Infections | 1993 |
Pharmacokinetics and relative bioavailability of lomefloxacin preparations in 10 healthy Chinese volunteers.
Topics: Adult; Anti-Infective Agents; Biological Availability; Capsules; Fluoroquinolones; Humans; Male; Quinolones; Tablets | 1993 |
Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchi; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mucous Membrane; Quinolones | 1993 |
[A clinical study on lomefloxacin to find appropriate dose levels in the treatment of respiratory tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Respiratory Tract Infections | 1993 |
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Canada; Double-Blind Method; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Prospective Studies; Quinolones; Treatment Outcome; Urinary Tract Infections | 1993 |
Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Norfloxacin; Quinolones; Treatment Outcome; Urinary Tract Infections; Urine | 1993 |
A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community.
Topics: Adult; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Community-Acquired Infections; Diarrhea; Double-Blind Method; Drug Resistance, Microbial; Feces; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Quinolones | 1995 |
Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Escherichia coli; Female; Fluoroquinolones; Humans; Italy; Klebsiella; Male; Middle Aged; Proteus; Pseudomonas; Quinolones; Streptococcus; Treatment Outcome; Urinary Tract Infections | 1996 |
Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Double-Blind Method; Drug Resistance; Fluoroquinolones; Fusidic Acid; Humans; Microbial Sensitivity Tests; Ophthalmic Solutions; Quinolones | 1996 |
Effect of ranitidine on renal clearance of lomefloxacin.
Topics: Adult; Anti-Infective Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Fluoroquinolones; Histamine H2 Antagonists; Humans; Male; Quinolones; Ranitidine | 1996 |
[Treatment of non-complicated acute cystitis in women: lomefloxacin versus pefloxacin].
Topics: Acute Disease; Adult; Anti-Infective Agents; Cystitis; Family Practice; Female; Fluoroquinolones; Humans; Middle Aged; Pefloxacin; Quinolones | 1996 |
[Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
Topics: Adult; Anti-Infective Agents; Cystitis; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Patient Acceptance of Health Care; Quinolones; Recurrence; Urinary Tract Infections | 1997 |
[Clinical efficacy of lomefloxacin for associated infection in patients with hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Female; Fluoroquinolones; Hematologic Diseases; Humans; Male; Middle Aged; Quinolones; Respiratory Tract Infections; Urinary Tract Infections | 1997 |
A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Quinolones; Urinary Tract Infections | 1998 |
[A clinical study in the treatment of acute bacterial infections with fleroxacin].
Topics: Adult; Anti-Infective Agents; Female; Fleroxacin; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Respiratory Tract Infections; Urinary Tract Infections | 1996 |
Typhoid fevers: treatment with lomefloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Resistance, Microbial; Female; Fluoroquinolones; Half-Life; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Salmonella; Salmonella paratyphi A; Salmonella paratyphi B; Salmonella typhi; Tropical Climate; Typhoid Fever | 1998 |
[Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis].
Topics: Acute Disease; Adolescent; Adult; Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Mice; Middle Aged; Pyrazinamide; Quinolones; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Lomefloxacin in phthisiatric practice].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Anti-Infective Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Glutamate Dehydrogenase; Humans; Male; Middle Aged; Quinolones; Transaminases; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Selection of antibacterial therapy for treatment of infections in elderly patients].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Quinolones; Respiratory Tract Infections | 1998 |
[Efficacy of lomefloxacin in treatment of patients with chronic bronchitis].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moraxella catarrhalis; Neisseria; Quinolones; Roxithromycin; Sputum; Staphylococcus aureus; Streptococcus | 1998 |
[Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
Topics: Adolescent; Adult; Anti-Infective Agents; Burns; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Pseudomonas Infections; Quinolones; Staphylococcal Infections | 1998 |
[Lomefloxacin in treatment of infectious eye diseases].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Conjunctivitis, Bacterial; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratitis; Male; Quinolones; Steroids; Treatment Outcome; Uveitis | 1998 |
[Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Postoperative Complications; Quinolones; Urinary Tract Infections; Urologic Surgical Procedures | 1998 |
[Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
Topics: Age Factors; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae | 1998 |
Photosensitivity reactions caused by lomefloxacin hydrochloride: a multicenter survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Female; Fluoroquinolones; Humans; Male; Middle Aged; Photosensitivity Disorders; Quinolones | 1998 |
Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Dermatitis, Phototoxic; Double-Blind Method; Fluoroquinolones; Humans; Male; Moxifloxacin; Photosensitizing Agents; Quinolines; Quinolones | 1999 |
Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Child; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Haemophilus Infections; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinolones; Staphylococcal Infections; Streptococcal Infections; Tobramycin; Treatment Outcome | 1999 |
[Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Quinolones; Sinusitis; Treatment Outcome | 1999 |
Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Osteomyelitis; Quinolones | 2000 |
[The importance of fluoroquinolones in treating pneumonia in the elderly].
Topics: Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Quinolones; Sputum; Time Factors | 1999 |
A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Male; Naphthyridines; Photosensitivity Disorders; Quinolones; Single-Blind Method; Skin; Ultraviolet Rays | 2000 |
Bioequivalence evaluation of lomefloxacin 400 mg tablets (Lomax versus Maxaquin in healthy human volunteers.
Topics: Adult; Analysis of Variance; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Fluoroquinolones; Half-Life; Humans; Male; Middle Aged; Quinolones; Tablets; Therapeutic Equivalency | 1999 |
[Maxaquin in the combined treatment of tuberculosis].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Culture Techniques; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Humans; Lung; Mice; Mycobacterium tuberculosis; Quinolones; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Fluoroquinolones; Humans; Male; Prostatitis; Pseudomonas; Quinolones; Treatment Outcome; Urinary Tract Infections | 2002 |
Determination of bioequivalence of lomefloxacin tablets using urinary excretion data.
Topics: Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Confidence Intervals; Cross-Over Studies; Fluoroquinolones; Humans; Male; Pilot Projects; Quinolones; Tablets; Therapeutic Equivalency | 2002 |
Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers.
Topics: Administration, Topical; Adolescent; Adult; Anti-Infective Agents; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Corneal Ulcer; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Statistics, Nonparametric; Treatment Outcome | 2004 |
Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Cefazolin; Double-Blind Method; Female; Fluoroquinolones; Gentamicins; Humans; Keratitis; Male; Ophthalmic Solutions; Prospective Studies; Quinolones | 2004 |
275 other study(ies) available for lomefloxacin and carbostyril
| Article | Year |
|---|---|
[Evaluation of proposed criteria of disk susceptibility testing for tosufloxacin and lomefloxacin in NCCLS guidelines and WHO standards].
Topics: Anti-Infective Agents; Bacteria; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Organizations; Quinolones; United States; World Health Organization | 1992 |
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
Topics: Anti-Infective Agents; Culture Media; Fluoroquinolones; Haemophilus influenzae; Humans; Meropenem; Microbial Sensitivity Tests; Quality Control; Quinolones; Regression Analysis; Thienamycins | 1992 |
Fluoroquinolone resistance. An evolving national problem or just a problem for some physicians?
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Fluoroquinolones; Humans; Quinolones | 1992 |
Lomefloxacin: development of a once-a-day quinolone. Proceedings of a symposium. April 23-25, 1990, Miami, Florida.
Topics: Anti-Infective Agents; Drug Administration Schedule; Fluoroquinolones; Humans; Quinolones | 1992 |
Lomefloxacin concentrations in bone after a single oral dose.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bone and Bones; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Hip Prosthesis; Humans; Male; Middle Aged; Osteoarthritis, Hip; Premedication; Quinolones | 1992 |
Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
Topics: Adult; Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Creatinine; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Kidney; Kidney Diseases; Linear Models; Male; Middle Aged; Quinolones | 1992 |
Pharmacokinetics of lomefloxacin in patients with cirrhosis.
Topics: Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Male; Middle Aged; Quinolones | 1992 |
In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Time Factors | 1992 |
Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
Topics: Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Ciprofloxacin; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1992 |
Fluoroquinolone (Lomefloxacin) International Surveillance Trial: a report of 30 months of monitoring in vitro activity.
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones | 1992 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
Topics: Agar; Anti-Infective Agents; Drug Stability; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quinolones | 1992 |
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
Topics: Anti-Infective Agents; Cefdinir; Ceftizoxime; Cephalosporins; Diffusion; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Quinolones | 1992 |
Two new fluoroquinolones.
Topics: Anti-Infective Agents; Clinical Trials as Topic; Drug Interactions; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Urinary Tract Infections | 1992 |
Lomefloxacin reaches U.S. market.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Quinolones; United States; United States Food and Drug Administration | 1992 |
Scarified photopatch testing in lomefloxacin photosensitivity.
Topics: Aged; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Quinolones; Ultraviolet Rays | 1992 |
Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells.
Topics: Animals; Anti-Infective Agents; Cell Line; Cell Survival; Cells, Cultured; Fibroblasts; Fluoroquinolones; Humans; Macrophages; Neutrophils; Opsonin Proteins; Peritoneal Dialysis, Continuous Ambulatory; Quinolones; Temperature; Vero Cells | 1992 |
Quinolone antibiotics.
Topics: Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Humans; Product Surveillance, Postmarketing; Quinolones | 1992 |
In vitro evaluation of E-4695, a new fluoro-naphthyridine.
Topics: Anti-Bacterial Agents; Azetidines; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones | 1992 |
In-vitro activity of lomefloxacin against pathogenic and environmental mycobacteria.
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Kinetics; Mycobacterium; Mycobacterium Infections; Quinolones | 1992 |
Effect of antacid on absorption of the quinolone lomefloxacin.
Topics: Adult; Aluminum; Antacids; Anti-Infective Agents; Chelating Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Intestinal Absorption; Magnesium; Magnetic Resonance Spectroscopy; Male; Middle Aged; Quinolones | 1992 |
In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones | 1992 |
Comparative study of penetration of lomefloxacin and ceftriaxone into transudative and exudative pleural effusion.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone; Exudates and Transudates; Female; Fluoroquinolones; Half-Life; Humans; Male; Middle Aged; Pleural Effusion; Quinolones | 1992 |
Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Chronic Disease; Female; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Quinolones; Respiratory Tract Infections; Sputum | 1992 |
Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
Topics: Animals; Anti-Infective Agents; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Pefloxacin; Quinolones | 1992 |
Influence of lomefloxacin on phagocytosis and killing activity of macrophages and neutrophils.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Mice; Mice, Inbred BALB C; Neutrophils; Phagocytosis; Quinolones | 1992 |
The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1992 |
Penetration of lomefloxacin into human prostatic tissue.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Premedication; Prostate; Prostatectomy; Prostatic Hyperplasia; Quinolones | 1992 |
Outer membrane changes in quinolone resistant Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Pseudomonas aeruginosa; Quinolones | 1991 |
Determination of lomefloxacin in biological fluids by high-performance liquid chromatography and a microbiological method.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Mice; Microbiological Techniques; Norfloxacin; Quinolones | 1991 |
The pharmacokinetics of lomefloxacin in elderly patients with urinary tract infection following daily dosing with 400 mg.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Drug Administration Schedule; Drug Evaluation; Fluoroquinolones; Humans; Quinolones; Urinary Tract Infections | 1991 |
Transport of the new quinolone antibacterial agents of lomefloxacin and ofloxacin by rat erythrocytes, and its relation to the nicotinic acid transport system.
Topics: Animals; Anti-Infective Agents; Biological Transport, Active; Erythrocytes; Fluoroquinolones; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Niacin; Ofloxacin; Osmolar Concentration; Quinolones; Rats; Rats, Inbred Strains; Temperature | 1991 |
Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Injections, Intravenous; Lung; Quinolones | 1991 |
Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluorescence; Fluoroquinolones; Humans; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1991 |
Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests; Quinolones | 1991 |
Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Leprosy; Mice; Mycobacterium leprae; Quinolones | 1991 |
Antimicrobial effects of lomefloxacin in vitro.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Quinolones; Urinary Tract Infections | 1991 |
Penetration of lomefloxacin into human prostatic tissue.
Topics: 4-Quinolones; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Prostate; Quinolones | 1991 |
Antibacterial activity of lomefloxacin.
Topics: 4-Quinolones; Anti-Infective Agents; Blood Proteins; Drug Stability; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quinolones; Urine | 1991 |
Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
Topics: 4-Quinolones; Administration, Oral; Anti-Infective Agents; Enterobacteriaceae; Feces; Female; Fluoroquinolones; Humans; Male; Quinolones; Staphylococcus; Streptococcus | 1991 |
In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Lactams; Microbial Sensitivity Tests; Quinolones | 1991 |
Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.
Topics: Anti-Infective Agents; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Quinolones; Tetracycline | 1991 |
[In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
Topics: Anti-Infective Agents; Antitubercular Agents; Fleroxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones | 1991 |
Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Quinolones; Reproducibility of Results; Ureaplasma | 1990 |
The possible mechanism of interaction between xanthines and quinolone.
Topics: Animals; Anti-Infective Agents; Blood Proteins; Bronchodilator Agents; Drug Interactions; Enoxacin; Fluoroquinolones; Male; Quinolones; Rats; Rats, Inbred Strains; Xanthines | 1990 |
Pharmacokinetics of lomefloxacin in renally compromised patients.
Topics: 4-Quinolones; Anti-Infective Agents; Female; Fluoroquinolones; Glucuronates; Half-Life; Humans; Kidney Diseases; Male; Quinolones; Renal Dialysis | 1990 |
Intraprostatic distribution of lomefloxacin following multiple-dose administration.
Topics: 4-Quinolones; Aged; Anti-Infective Agents; Fluoroquinolones; Humans; Intraoperative Period; Male; Middle Aged; Prostate; Quinolones | 1990 |
In vitro toxicity of lomefloxacin in rabbit corneal epithelial cell cultures.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Cell Count; Cell Survival; Cells, Cultured; Cornea; Epithelium; Eye Proteins; Fluoroquinolones; Mitochondria; Quinolones; Rabbits; Succinate Dehydrogenase; Wound Healing | 1990 |
Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; Neutrophils; Norfloxacin; Nucleic Acids; Phagocytosis; Pseudomonas aeruginosa; Quinolones; Tritium | 1990 |
[A clinical study of asymptomatic bacteriospermia].
Topics: 4-Quinolones; Anti-Infective Agents; Cephalexin; Cephalosporins; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Moxalactam; Quinolones; Semen; Staphylococcus epidermidis; Streptococcus agalactiae | 1990 |
Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model.
Topics: 4-Quinolones; Administration, Oral; Anti-Infective Agents; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1990 |
Antibacterial activity of fluoroquinolones in combination with zidovudine.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Quinolones; Salmonella; Staphylococcus; Zidovudine | 1990 |
Mechanism of action of lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Rec A Recombinases | 1990 |
Treatment of experimental Salmonella typhimurium infection in mice with lomefloxacin.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Female; Fluoroquinolones; Half-Life; Mice; Quinolones; Salmonella Infections, Animal; Salmonella typhimurium | 1990 |
Lomefloxacin disc susceptibility criteria--a reappraisal.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1990 |
The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Drug Administration Schedule; Drug Interactions; Female; Fluoroquinolones; Humans; Injections, Intravenous; Kidney; Male; Quinolones; Theophylline | 1990 |
Effect of food on absorption of lomefloxacin.
Topics: 4-Quinolones; Absorption; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Food; Humans; Male; Quinolones; Time Factors | 1990 |
[Physiologic model of NY-198 pharmacokinetics using a new method of determining tissue/blood distribution coefficient].
Topics: 4-Quinolones; Adipose Tissue; Animals; Anti-Infective Agents; Fluoroquinolones; Humans; Metabolic Clearance Rate; Models, Biological; Muscles; Quinolones; Time Factors; Viscera | 1990 |
Effect of lomefloxacin on the normal oral and intestinal microflora.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Feces; Female; Fluoroquinolones; Humans; Intestines; Male; Middle Aged; Quinolones; Saliva; Time Factors | 1990 |
Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Female; Fluoroquinolones; Half-Life; Humans; Kidney Failure, Chronic; Male; Middle Aged; Quinolones; Reference Values; Renal Dialysis | 1990 |
[Clinical effect of NY-198 (lomefloxacin) for sexually transmitted disease--bacteriological effect of U. urealyticum].
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Chlamydia trachomatis; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Sexually Transmitted Diseases; Ureaplasma | 1990 |
[Therapeutic drug monitoring of fluoroquinolone].
Topics: Anti-Infective Agents; Bile; Biological Assay; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones; Sputum | 1990 |
Lomefloxacin sensitivities.
Topics: 4-Quinolones; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Predictive Value of Tests; Quinolones | 1990 |
[A new method of calculating tissue/blood distribution coefficient in physiological models of pharmacokinetics].
Topics: 4-Quinolones; Ampicillin; Anti-Infective Agents; Blood; Fluoroquinolones; Humans; Models, Biological; Pharmacokinetics; Quinolones; Sulbactam; Tissue Distribution; Xenobiotics | 1990 |
Concentrations of oral lomefloxacin in serum and bronchial mucosa.
Topics: 4-Quinolones; Administration, Oral; Adult; Aged; Anti-Infective Agents; Bronchi; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mucous Membrane; Quinolones | 1990 |
Influence of lomefloxacin on the pharmacokinetics of theophylline.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Humans; Male; Metabolic Clearance Rate; Quinolones; Theophylline | 1990 |
Susceptibility pattern of bacterial isolates to lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Nalidixic Acid; Norfloxacin; Quinolones | 1990 |
[Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Bacterial Proteins; DNA, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; RNA, Bacterial; Staphylococcus aureus | 1989 |
Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Ciliary Body; Drug Administration Routes; Eye; Female; Fluoroquinolones; In Vitro Techniques; Iris; Melanins; Microbial Sensitivity Tests; Quinolones; Rabbits; Tissue Distribution | 1989 |
In-vitro activity of lomefloxacin in comparison with pefloxacin and ofloxacin.
Topics: Aeromonas; Anti-Infective Agents; Campylobacter; Corynebacterium; Enterobacteriaceae; Fluoroquinolones; Haemophilus; Neisseria gonorrhoeae; Ofloxacin; Pefloxacin; Quinolones; Staphylococcus aureus | 1989 |
Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Ceftazidime; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Norfloxacin; Quinolones | 1989 |
Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Dose-Response Relationship, Drug; Enterobacteriaceae; Fluoroquinolones; Humans; Intestinal Absorption; Male; Middle Aged; Neisseria; Quinolones; Tissue Distribution | 1989 |
Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16.
Topics: Anti-Infective Agents; Enoxacin; Escherichia coli; Fluoroquinolones; Quinolones | 1989 |
Studies on the emergence of resistance to lomefloxacin in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Cystitis; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Biological; Norfloxacin; Quinolones | 1989 |
[Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose].
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Humans; Klebsiella pneumoniae; Middle Aged; Quinolones; Staphylococcus | 1989 |
Antibacterial and plasmid curing activity of lomefloxacin in vitro.
Topics: Anti-Infective Agents; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Plasmids; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1989 |
In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Chlamydia trachomatis; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quinolones; Spectinomycin; Tetracycline | 1989 |
Kinetic interaction between theophylline and a newly developed quinolone, NY-198.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Humans; Male; Quinolones; Theophylline | 1989 |
Effect of lomefloxacin on theophylline pharmacokinetics.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Half-Life; Humans; Immunoenzyme Techniques; Male; Quinolones; Theophylline | 1989 |
In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections | 1989 |
[Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
Topics: 4-Quinolones; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Body Fluids; Fluoroquinolones; Humans; Male; Middle Aged; Prostate; Prostatitis; Quinolones; Time Factors | 1989 |
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluoroquinolones; Humans; Male; Nicotinic Acids; Pipemidic Acid; Quinolines; Quinolones; Theophylline | 1989 |
Serum protein binding of lomefloxacin, a new antimicrobial agent, and its related quinolones.
Topics: Animals; Anti-Infective Agents; Blood Proteins; Dogs; Fluoroquinolones; Humans; Nalidixic Acid; Ofloxacin; Protein Binding; Quinolones; Rats; Species Specificity | 1989 |
[Studies of lomefloxacin in biliary tract infections].
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Bacteria; Bacterial Infections; Biliary Tract Diseases; Drug Evaluation; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones | 1989 |
In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Drug Combinations; Enterobacteriaceae; Fluoroquinolones; Lactams; Leucomycins; Microbial Sensitivity Tests; Miocamycin; Netilmicin; Quinolones; Staphylococcus; Streptococcus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Lomefloxacin sensitivities.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1989 |
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Diarrhea; Fluoroquinolones; Humans; Quinolones | 1989 |
[In vitro evaluation of lomefloxacin].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones | 1989 |
In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.
Topics: Anti-Infective Agents; Chlamydia; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Naphthyridines; Quinolones | 1988 |
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin | 1988 |
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Blood Proteins; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Ofloxacin; Oxazines; Protein Binding; Pseudomonas aeruginosa; Quinolines; Quinolones; Staphylococcus; Streptococcus; Trimethoprim | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Topics: Anti-Infective Agents; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Fleroxacin; Fluoroquinolones; Minocycline; Norfloxacin; Ofloxacin; Quinolones | 1988 |
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Magnesium; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones | 1988 |
Entry of the new quinolone antibacterial agents of ofloxacin and NY-198 into the central nervous system in rats.
Topics: Animals; Anti-Infective Agents; Blood-Brain Barrier; Brain; Fluoroquinolones; Male; Ofloxacin; Quinolones; Rats; Rats, Inbred Strains; Tissue Distribution | 1988 |
Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Topics: 4-Quinolones; Administration, Oral; Adult; Anti-Infective Agents; Body Fluids; Chromatography, High Pressure Liquid; Fluoroquinolones; Half-Life; Humans; Male; Quinolones; Urinary Tract Infections | 1988 |
Efficacy of NY-198 against experimental Legionnaires disease.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Guinea Pigs; Legionnaires' Disease; Male; Quinolones; Tissue Distribution | 1988 |
Reproductive studies of NY-198 in rats. I. Fertility study.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Weight; Drinking; Eating; Female; Fertility; Fluoroquinolones; Male; Quinolones; Rats; Salivation | 1988 |
Reproductive studies of NY-198 in rats. II. Teratology study.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Weight; Embryonic and Fetal Development; Female; Fetus; Fluoroquinolones; Male; Quinolones; Rats; Reproduction | 1988 |
Reproductive studies of NY-198 in rats. III. Perinatal and postnatal study.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Weight; Drinking; Eating; Embryonic and Fetal Development; Female; Fluoroquinolones; Lactation; Male; Pregnancy; Pregnancy, Animal; Quinolones; Rats; Reproduction | 1988 |
Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Experimental; Female; Fluoroquinolones; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin; Pyelonephritis; Quinolones; Respiratory Tract Infections; Urinary Tract Infections | 1988 |
[Studies on intraocular penetration of NY-198 (Lomefloxacin) eye drops].
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Chemical Phenomena; Chemistry; Eye; Fluoroquinolones; Ophthalmic Solutions; Quinolones; Rabbits; Tissue Distribution | 1988 |
[The influence of melanin on intraocular dynamics].
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Eye; Female; Fluoroquinolones; Melanins; Quinolones; Rabbits; Tissue Distribution | 1988 |
In-vitro assessment of lomefloxacin (SC-47111)--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1988 |
Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Staphylococcus | 1988 |
[Chemotherapy for biliary tract infection (XXXIII). Tissue concentration of NY-198 in gallbladder, biliary excretion and clinical effects].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Bile; Cholangitis; Cholecystitis; Drug Evaluation; Enoxacin; Female; Fluoroquinolones; Gallbladder; Humans; Male; Middle Aged; Quinolones; Tissue Distribution | 1988 |
Enterohepatic circulation of NY-198, a new difluorinated quinolone, in rats.
Topics: Animals; Anti-Infective Agents; Bile; Enterohepatic Circulation; Fluoroquinolones; Intestinal Mucosa; Liver; Male; Quinolines; Quinolones; Rats; Rats, Inbred Strains | 1988 |
In vitro and in vivo activity of NY-198, a new difluorinated quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Quinolines; Quinolones | 1987 |
Reevaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sensitivity and Specificity | 1995 |
[A case of cystic fibrosis in a Japanese student].
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cystic Fibrosis; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Japan; Male; Pseudomonas Infections; Quinolones; Respiratory Tract Infections | 1995 |
[Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
Topics: Anti-Infective Agents; Combined Modality Therapy; Fluoroquinolones; Humans; Kidney Failure, Chronic; Quinolones; Renal Dialysis | 1995 |
[Lomefloxacin concentration in human prostatic tissue following 3-day administration].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Premedication; Prostate; Prostatectomy; Prostatic Hyperplasia; Quinolones | 1993 |
Fluoroquinolone-induced depression.
Topics: Adult; Anti-Infective Agents; Depressive Disorder; Female; Fluoroquinolones; Humans; Quinolones; Substance-Related Disorders; Urinary Tract Infections | 1995 |
Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1995 |
[Use of a new drug, lomefloxacin (maxaquin), from the fluoroquinolone group in the treatment of patients with wound infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Wound Infection | 1994 |
The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect.
Topics: Anti-Infective Agents; Biotransformation; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Staphylococcus aureus | 1994 |
In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Fluoroquinolones; Norfloxacin; Ofloxacin; Proteus; Providencia; Quinolones; Surface Properties; Urea; Urease | 1995 |
[Comparative evaluation of the effectiveness of fluoroquinolones in experimental anthrax infection].
Topics: Animals; Anthrax; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fluoroquinolones; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Pefloxacin; Quinolones | 1994 |
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Drug Evaluation, Preclinical; Drug Labeling; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; United States; United States Food and Drug Administration | 1994 |
In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
Topics: Absorption; Anti-Infective Agents; Azides; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Lipid Peroxidation; Norfloxacin; Ofloxacin; Oxygen; Photochemistry; Photosensitivity Disorders; Quinolones; Sodium Azide; Squalene; Ultraviolet Rays | 1994 |
Henoch-Schönlein purpura induced by fluoroquinolones.
Topics: Anti-Infective Agents; Cinoxacin; Cystitis; Female; Fluoroquinolones; Humans; IgA Vasculitis; Middle Aged; Quinolones | 1994 |
The determination of ofloxacin in human skin tissue by high-performance liquid chromatography and correlation between skin tissue concentration and serum level of ofloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Ofloxacin; Quinolones; Skin | 1994 |
Effect of subinhibitory concentrations of lomefloxacin on bacterial adherence.
Topics: Anti-Infective Agents; Bacterial Adhesion; Dose-Response Relationship, Drug; Escherichia coli; Fimbriae, Bacterial; Fluoroquinolones; Quinolones; Staphylococcus | 1994 |
Bullous photodermatosis after lomefloxacin.
Topics: Aged; Anti-Infective Agents; Dermatitis, Phototoxic; Fluoroquinolones; Humans; Male; Quinolones; Skin Diseases, Vesiculobullous | 1994 |
Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits.
Topics: Animals; Anterior Chamber; Anti-Infective Agents; Colony Count, Microbial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gentamicins; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rabbits; Sulbenicillin | 1993 |
Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration.
Topics: Adult; Aged; Alveolar Process; Anti-Infective Agents; Female; Fluoroquinolones; Gingiva; Gingival Diseases; Humans; Male; Middle Aged; Quinolones; Radicular Cyst | 1993 |
[Highperformance liquid chromatographic assay for lomefloxacin in plasma and its pharmacokinetics in healthy volunteers].
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Quinolones | 1993 |
Intraphagocytic bioactivity of lomefloxacin against Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Cell Survival; Cells, Cultured; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Phagocytes; Phagocytosis; Phenylbutazone; Pseudomonas aeruginosa; Quinolones | 1993 |
[Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Fluoroquinolones; Helicobacter pylori; Humans; In Vitro Techniques; Ofloxacin; Pefloxacin; Quinolones; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1993 |
New drugs from 1991-1992.
Topics: 1-Naphthylamine; Anti-Bacterial Agents; Anti-Infective Agents; Anticholesteremic Agents; Antineoplastic Agents; Antiviral Agents; Azithromycin; Butanones; Cardiovascular Agents; Clarithromycin; Drug Approval; Drug Combinations; Drug Interactions; Enoxacin; Finasteride; Flumazenil; Fluoroquinolones; Humans; Ketorolac Tromethamine; Lactams; Nabumetone; Pyridines; Quinolones; Sertraline; Tolmetin; Tromethamine; United States; United States Food and Drug Administration; Zolpidem | 1993 |
Lomefloxacin photosensitivity.
Topics: Adult; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Photosensitivity Disorders; Quinolones | 1994 |
Selection of a fluoroquinolone-class disk for susceptibility tests.
Topics: Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1993 |
A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
[Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bone and Bones; Fluoroquinolones; Haemophilus influenzae; Joints; Male; Microbial Sensitivity Tests; Naphthyridines; Quinolones; Rabbits; Staphylococcus aureus; Streptococcus pyogenes | 1993 |
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.
Topics: Animals; Anti-Infective Agents; Drug Administration Schedule; Female; Fluoroquinolones; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rats; Rats, Sprague-Dawley | 1993 |
Characterization of the complexation of fluoroquinolone antimicrobials with metal ions by nuclear magnetic resonance spectroscopy.
Topics: Anti-Infective Agents; Cations, Divalent; Fluoroquinolones; Magnetic Resonance Spectroscopy; Metals; Molecular Structure; Norfloxacin; Quinolones; X-Ray Diffraction | 1993 |
[Effects of lomefloxacin on the rabbit retina].
Topics: Animals; Anti-Infective Agents; Electroretinography; Fluoroquinolones; In Vitro Techniques; Quinolones; Rabbits; Receptors, GABA-A; Retina | 1993 |
Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Topics: Anti-Infective Agents; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quinolones | 1993 |
Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Topics: Adult; Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infections; Ofloxacin; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Urinary Tract Infections | 1993 |
A 19F NMR study of lomefloxacin in human erythrocytes and its interaction with hemoglobin.
Topics: Anti-Infective Agents; Binding Sites; Edetic Acid; Erythrocytes; Fluoroquinolones; Hemoglobins; Humans; Magnetic Resonance Spectroscopy; Protein Binding; Quinolones | 1995 |
Stereospecific high-performance liquid chromatographic assay of lomefloxacin in human plasma.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Quinolones; Stereoisomerism | 1995 |
Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Diffusion; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Quinolones | 1995 |
Effects of lomefloxacin and sparfloxacin on human platelet aggregation.
Topics: Adenosine Diphosphate; Adult; Aged; Anti-Infective Agents; Collagen; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinolones; Reference Values | 1995 |
The UVR wavelength dependence for lomefloxacin photosensitization of human skin.
Topics: Adult; Anti-Infective Agents; Erythema; Female; Fluoroquinolones; Humans; Male; Middle Aged; Molecular Structure; Photosensitizing Agents; Quinolones; Skin; Spectrophotometry, Ultraviolet; Ultraviolet Rays | 1996 |
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
Topics: Anti-Infective Agents; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Quinolones; Streptococcus pneumoniae | 1996 |
Multi-center validation of proposed disk diffusion susceptibility testing interpretive criteria for lomefloxacin using more than 1,500 clinical isolates.
Topics: Anti-Infective Agents; Bacteria; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quinolones | 1996 |
Detection of quinolone-resistant Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Fleroxacin; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Quinolones; Reference Standards | 1996 |
[Pharmacokinetics of norfloxacin and lomefloxacin in aqueous humour analysed by microdialysis].
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Fluoroquinolones; Microdialysis; Norfloxacin; Quinolones; Rabbits | 1996 |
[Effect of lomefloxacin on luminol-dependent chemiluminescence and adhesion of leukocytes].
Topics: Animals; Anti-Infective Agents; Cell Adhesion; Fluoroquinolones; Guinea Pigs; Leukocytes; Luminescent Measurements; Luminol; Quinolones | 1996 |
Automated analytical systems for drug development studies. Part IV. A microdialysis system to study the partitioning of lomefloxacin across an erythrocyte membrane in vitro.
Topics: Adult; Anti-Infective Agents; Autoanalysis; Chemical Phenomena; Chemistry, Physical; Chromatography, Liquid; Erythrocyte Membrane; Fluoroquinolones; Humans; In Vitro Techniques; Microdialysis; Quinolones | 1995 |
Effect of probenecid and ranitidine on urinary excretion of lomefloxacin in rats.
Topics: Animals; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Male; Probenecid; Quinolones; Ranitidine; Rats; Rats, Wistar | 1996 |
The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay).
Topics: Animals; Anti-Infective Agents; Carcinogens; Chromosome Aberrations; Ciprofloxacin; Cricetinae; DNA Damage; Fleroxacin; Fluoroquinolones; Gene Conversion; Lymphoma; Methoxsalen; Mice; Mitosis; Mutagenicity Tests; Mutagens; Mutation; Photosensitizing Agents; Quinolones; Saccharomyces cerevisiae; Salmonella; Tumor Cells, Cultured; Ultraviolet Rays | 1996 |
Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high-followed by low-dosage regimen.
Topics: Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoroquinolones; Guinea Pigs; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Time Factors | 1995 |
The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies.
Topics: Animals; Anti-Infective Agents; Fluorine Radioisotopes; Fluoroquinolones; Humans; Isotope Labeling; Male; Quinolones; Radiochemistry; Swine; Tissue Distribution; Whole-Body Counting | 1996 |
[Effect of lomefloxacin on the functional activity of the phagocytic system].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Drug Evaluation, Preclinical; Fluoroquinolones; Luminescent Measurements; Macrophages, Alveolar; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxygen; Phagocytosis; Quinolones | 1996 |
[Effect of lomefloxacin on the synthesis of antibodies to vaccine EV fraction I and hemagglutinins].
Topics: Animals; Anti-Infective Agents; Antigens, Bacterial; Erythrocytes; Fluoroquinolones; Hemagglutinins; Immunization; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Mice; Quinolones; Sheep | 1996 |
[Effect of drugs of the fluoroquinolone series on morphokinetic parameters of the cellular elements of lung tissue].
Topics: Animals; Anti-Infective Agents; Cell Division; Ciprofloxacin; Culture Techniques; Dogs; Fluoroquinolones; Guinea Pigs; Lung; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Ofloxacin; Quinolones | 1996 |
[Antitubercular activity of lomefloxacin in an experiment].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoroquinolones; Isoniazid; Lung; Mice; Mycobacterium tuberculosis; Quinolones; Reference Values; Spleen; Survival Rate; Tuberculosis | 1996 |
[Uptake of 5 fluoroquinolones into human polymorphonuclear cells].
Topics: Anti-Infective Agents; Biological Transport; Fleroxacin; Fluorometry; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Levofloxacin; Neutrophils; Norfloxacin; Ofloxacin; Quinolones; Temperature | 1996 |
Photogeneration of fluoride by the fluoroquinolone antimicrobial agents lomefloxacin and fleroxacin.
Topics: Anti-Infective Agents; Fleroxacin; Fluorides; Fluoroquinolones; Magnetic Resonance Spectroscopy; Quinolones | 1997 |
Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fleroxacin; Fluoroquinolones; Mice; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Quinolones; Skin Neoplasms; Ultraviolet Rays | 1997 |
Quinolone antibacterials: a new class of photochemical carcinogens.
Topics: Animals; Anti-Infective Agents; Carcinoma, Squamous Cell; Ciprofloxacin; Dermatitis, Phototoxic; Fleroxacin; Fluoroquinolones; Methoxsalen; Mice; Mice, Hairless; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Papilloma; Quinolones; Skin Neoplasms | 1997 |
[Use of fluoroquinolones in rheumatology].
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Tolerance; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Pefloxacin; Quinolones; Rheumatic Diseases; Time Factors | 1996 |
[Bactericidal effects of maxaquin on mycobacterium tuberculosis].
Topics: Animals; Anti-Infective Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluoroquinolones; In Vitro Techniques; Lung; Mice; Mycobacterium tuberculosis; Quinolones | 1997 |
Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dermatitis, Phototoxic; DNA; DNA Damage; Enoxacin; Fluoroquinolones; Free Radical Scavengers; Hematoporphyrins; Molecular Structure; Ofloxacin; Oxygen; Photosensitizing Agents; Quinolones; Reactive Oxygen Species; Spectroscopy, Near-Infrared; Superoxides | 1997 |
Quinolone antibiotic photodynamic production of 8-oxo-7, 8-dihydro-2'-deoxyguanosine in cultured liver epithelial cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Cell Line; Chromatography, High Pressure Liquid; Ciprofloxacin; Deoxyguanosine; Electrochemistry; Epithelial Cells; Epithelium; Fluoroquinolones; Liver; Photosensitizing Agents; Quinolones; Rats; Spectrophotometry, Ultraviolet | 1997 |
[A chronobiological study of the function of the epithelial proliferative system of the murine esophagus after its infection with typhoid and the use of lomefloxacin].
Topics: Animals; Anti-Infective Agents; Cell Division; Chronobiology Phenomena; Disease Models, Animal; Drug Evaluation, Preclinical; Epithelium; Esophageal Diseases; Esophagus; Fluoroquinolones; Male; Mice; Mitotic Index; Quinolones; Time Factors; Typhoid Fever | 1996 |
A study of the phototoxic potential of trovafloxacin in BALB/c mice.
Topics: Animals; Anti-Infective Agents; Dermatitis, Phototoxic; Erythema; Female; Fluoroquinolones; Hypertrophy; Mice; Mice, Inbred BALB C; Naphthyridines; Quinolones; Skin; Ultraviolet Rays | 1997 |
[Chronobiological study of cell proliferation in esophageal epithelium of mice treated with lomefloxacin at different time of day].
Topics: Animals; Anti-Infective Agents; Cell Division; Circadian Rhythm; Epithelial Cells; Esophagus; Fluoroquinolones; Male; Mice; Quinolones | 1994 |
In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Culture Media; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1997 |
[Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Disease Progression; Drug Resistance, Microbial; Fluoroquinolones; Follow-Up Studies; Humans; Middle Aged; Mycobacterium tuberculosis; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Respiratory Tract Infections | 1997 |
Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
Topics: Anti-Infective Agents; Antitubercular Agents; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Quinolones | 1997 |
Proposed mechanism for the photodynamic generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine produced in cultured cells by exposure to lomefloxacin.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Antioxidants; Butylated Hydroxyanisole; Cells, Cultured; Deoxyguanosine; Fluoroquinolones; Liver; Mannitol; Photosensitizing Agents; Quinolones; Rats; Reactive Oxygen Species; Sodium Azide; Ultraviolet Rays; Vitamin E | 1997 |
Ocular distribution of lomefloxacin 0.3% after a single instillation in the infected eye of pigmented rabbits.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Area Under Curve; Biological Availability; Cornea; Eye Infections, Bacterial; Fluoroquinolones; Male; Pseudomonas Infections; Quinolones; Rabbits | 1997 |
In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1998 |
Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Dermatitis, Photoallergic; Fleroxacin; Fluoroquinolones; Humans; Male; Quinolones | 1998 |
[Lomefloxacin hydrochloride (Maxaquin), a long-acting fluoroquinolone (information for specialists)].
Topics: Anti-Infective Agents; Contraindications; Delayed-Action Preparations; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones | 1998 |
Involvement of reactive oxygen species, protein kinase C, and tyrosine kinase in prostaglandin E2 production in Balb/c 3T3 mouse fibroblast cells by quinolone phototoxicity.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Cell Membrane; Dinoprostone; Fluoroquinolones; Interleukin-1; Mice; Mice, Inbred BALB C; Photosensitizing Agents; Protein Kinase C; Protein-Tyrosine Kinases; Quinolones; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 1998 |
Inhibition by singlet oxygen quenchers of oxidative damage to DNA produced in cultured cells by exposure to a quinolone antibiotic and ultraviolet A irradiation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Cell Line; Deoxyguanosine; DNA; Fluoroquinolones; Oxygen; Photochemistry; Quinolones; Rats; Reactive Oxygen Species; Singlet Oxygen; Ultraviolet Rays | 1998 |
Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; Extremities; Fleroxacin; Fluoroquinolones; Magnesium Deficiency; Mice; Microscopy, Electron; Ofloxacin; Pefloxacin; Quinolones | 1998 |
Photocleavage of DNA by the fluoroquinolone antibacterials.
Topics: Anti-Infective Agents; DNA Damage; Enoxacin; Fleroxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Photolysis; Plasmids; Quinolones; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
[Mechanism of action of lomefloxacin on Mycobacterium tuberculosis].
Topics: Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cell Wall; Colony Count, Microbial; Cytoplasm; Drug Antagonism; Fluoroquinolones; Macrophages, Alveolar; Mice; Microscopy, Electron; Mycobacterium tuberculosis; Quinolones; Rifampin | 1998 |
Structure and medium-dependent photodecomposition of fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Enoxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Photolysis; Photosensitizing Agents; Quantum Theory; Quinolones; Structure-Activity Relationship | 1998 |
Comparison of the complexation of fluoroquinolone antimicrobials with metal ions by nuclear magnetic resonance spectroscopy.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Magnetic Resonance Spectroscopy; Metals; Ofloxacin; Quinolones; Solutions; Temperature | 1999 |
Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat.
Topics: Animals; Anti-Infective Agents; Biliary Tract; Biological Transport; Cells, Cultured; Fluoroquinolones; Liver; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley | 1999 |
[The uptake of fluoroquinolone agent drugs by cultured human conjunctival epithelial cells and cultured SIRC rabbit corneal cells].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Conjunctiva; Cornea; Epithelial Cells; Fluoroquinolones; Humans; Norfloxacin; Ofloxacin; Quinolones; Rabbits | 1999 |
Diffuse reflectance near-infrared spectroscopy as a nondestructive analytical technique for polymer implants.
Topics: Anti-Infective Agents; Drug Implants; Fluoroquinolones; Polyesters; Polyethylene Glycols; Quinolones; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared | 1999 |
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Lipopolysaccharides; Microbial Sensitivity Tests; Mutation; Norfloxacin; Quinolones | 1999 |
In vitro phototoxicity of new quinolones: production of active oxygen species and photosensitized lipid peroxidation.
Topics: Anti-Infective Agents; Ciprofloxacin; Dermatitis, Phototoxic; DNA Damage; Fleroxacin; Fluoroquinolones; Humans; Lipid Peroxidation; Norfloxacin; Ofloxacin; Quinolones; Reactive Oxygen Species; Squalene; Time Factors; Ultraviolet Rays | 1999 |
Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Corneal Ulcer; Eye; Female; Fluoroquinolones; Hydrogen-Ion Concentration; Male; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1999 |
The phototumorigenic fluoroquinolone lomefloxacin photosensitizes pyrimidine dimer formation in human keratinocytes in vitro.
Topics: Anti-Infective Agents; Cell Line, Transformed; DNA Damage; Fluoroquinolones; Humans; Keratinocytes; Photosensitizing Agents; Pyrimidine Dimers; Quinolones | 1999 |
[Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Isoniazid; Middle Aged; Quinolones; Respiratory Tract Infections; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |
Differences in the photogenotoxic potential of two fluoroquinolones as shown in diploid yeast strain (Saccharomyces cerevisae) and supercoiled plasmid DNA.
Topics: Adenosine Triphosphatases; Anti-Infective Agents; Cell Division; Diploidy; DNA Helicases; DNA, Superhelical; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluoroquinolones; Mutagenicity Tests; Mutation; Photosensitizing Agents; Plasmids; Quinolones; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Time Factors; Ultraviolet Rays | 2000 |
Photosensitivity to lomefloxacin. A clinical and photobiological study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Dermatitis, Phototoxic; Drug Hypersensitivity; Facial Dermatoses; Female; Fluoroquinolones; Humans; Male; Middle Aged; Patch Tests; Photosensitizing Agents; Quinolones; Ultraviolet Rays | 2000 |
[The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia].
Topics: Aerosols; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoroquinolones; Mice; Particle Size; Quinolones; Research Design; Tularemia | 2000 |
Patients with infectious gastroenteritis in New Zealand rarely need antimicrobial treatment.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Drug Resistance, Microbial; Escherichia coli Infections; Fluoroquinolones; Gastroenteritis; Humans; New Zealand; Practice Patterns, Physicians'; Quinolones; Salmonella Infections | 2000 |
Possible relationship between phototoxicity and photodegradation of sitafloxacin, a quinolone antibacterial agent, in the auricular skin of albino mice.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Dermatitis, Phototoxic; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Photolysis; Quinolones; Time Factors; Ultraviolet Rays | 2000 |
Distinct mechanisms of guanine-specific DNA photodamage induced by nalidixic acid and fluoroquinolone antibacterials.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Anti-Infective Agents; Binding Sites; Deoxyguanosine; DNA; DNA Damage; Electron Transport; Fluoroquinolones; Free Radical Scavengers; Genes, p53; Genes, ras; Guanine; Humans; In Vitro Techniques; Nalidixic Acid; Proto-Oncogene Mas; Quinolones; Ultraviolet Rays | 2000 |
Fluoroquinolone pharmacodynamics: prospective determination of relationships between exposure and outcome.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Models, Biological; Mutation; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rats; Treatment Outcome | 2000 |
Unusual cause of hematuria.
Topics: Agricultural Workers' Diseases; Animals; Anti-Infective Agents; Biopsy, Needle; Cystoscopy; Fluoroquinolones; Follow-Up Studies; Hematuria; Humans; India; Leeches; Male; Middle Aged; Quinolones | 2001 |
A thermodynamic study of complexation of ciprofloxacin and lomefloxacin with aluminium ion.
Topics: Aluminum; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Drug Stability; Entropy; Fluoroquinolones; Quinolones; Thermodynamics | 2000 |
Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones.
Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Cytoplasm; Fibroblasts; Fluoroquinolones; Humans; Mitochondria; Norfloxacin; Ofloxacin; Photosensitizing Agents; Quinolones; Skin | 2000 |
The phototumorigenic fluoroquinolone, lomefloxacin, photosensitises p53 accumulation and transcriptional activity in human skin cells.
Topics: Anti-Infective Agents; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; Fluoroquinolones; Humans; Hydrogen Peroxide; Molecular Structure; Photosensitizing Agents; Quinolones; Skin; Transcription, Genetic; Tumor Suppressor Protein p53 | 2000 |
Analyses of cutaneous fluoroquinolones photoreactivity using the integrated model for the differentiation of skin reactions.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Biomarkers; Cell Membrane; Enoxacin; Female; Fluoroquinolones; Irritants; Mice; Models, Biological; Ofloxacin; Phenotype; Photosensitizing Agents; Quinolones; Skin | 2000 |
Photochemical decomposition of lomefloxacin in vitro and in vivo.
Topics: Animals; Anti-Infective Agents; Buffers; Erythrocytes; Fluoroquinolones; Hemolysis; Leukocytes; Male; Molecular Structure; Photochemistry; Quinolones; Rats; Rats, Wistar | 2000 |
The role of lomefloxacin in the treatment of chronic prostatitis.
Topics: Aged; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Prostate; Prostatitis; Quinolones; Seminal Vesicles | 2001 |
Fluoroquinolones as chemical tools to define a strategy for photogenotoxicity in vitro assessment.
Topics: Anti-Infective Agents; Cell Line; Comet Assay; DNA Damage; DNA, Superhelical; Fluoroquinolones; Humans; In Vitro Techniques; Melanocytes; Monophenol Monooxygenase; Mutagenicity Tests; Photochemistry; Pigmentation; Quinolones; Saccharomyces cerevisiae; Skin; Tumor Suppressor Protein p53; Ultraviolet Rays | 2001 |
Lomefloxacin is an effective treatment of experimental bacterial keratitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Drug Evaluation, Preclinical; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Microbial Sensitivity Tests; Models, Animal; Ophthalmic Solutions; Quinolones; Rabbits | 2001 |
Simple high-performance liquid chromatographic assay for the determination of ciprofloxacin in human plasma with ultraviolet detection.
Topics: Anti-Infective Agents; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Humans; Molecular Structure; Quinolones; Reproducibility of Results | 2001 |
Multifaceted photoreactivity of 6-fluoro-7-aminoquinolones from the lowest excited states in aqueous media: a study by nanosecond and picosecond spectroscopic techniques.
Topics: Anti-Infective Agents; Fluoroquinolones; Photochemistry; Photosensitizing Agents; Quinolines; Quinolones; Solvents; Spectrum Analysis; Time Factors | 2001 |
Differential-pulse adsorptive stripping voltammetric determination of the antibacterial lomefloxacin.
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Quinolones | 2001 |
Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
Topics: Administration, Oral; Anti-Infective Agents; Antitubercular Agents; Bronchi; Bronchoalveolar Lavage Fluid; Fluoroquinolones; Humans; Lung; Microbial Sensitivity Tests; Pulmonary Disease, Chronic Obstructive; Quinolones | 2001 |
[Degradation of liquid preparations of four fluoroquinolones by factorial experiment. ].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Light; Norfloxacin; Ofloxacin; Quinolones | 1997 |
Disposable 1-day Acuvue contact lenses for the delivery of lomefloxacin to rabbits' eyes.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Biological Availability; Contact Lenses, Hydrophilic; Cornea; Disposable Equipment; Drug Delivery Systems; Female; Fluoroquinolones; Quinolones; Rabbits | 2001 |
Studies on the uptake and release of fluoroquinolones by disposable contact lenses.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Contact Lenses, Hydrophilic; Disposable Equipment; Drug Delivery Systems; Fluoroquinolones; Norfloxacin; Ofloxacin; Quinolones | 2001 |
[The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
Topics: Anti-Infective Agents; Dysentery, Bacillary; Escherichia coli; Fleroxacin; Fluoroquinolones; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Quinolones; Serum Bactericidal Test; Shigella dysenteriae; Staphylococcus aureus | 1999 |
Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents; Bronchitis; Cross-Sectional Studies; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Theophylline | 2001 |
Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Infective Agents; Calcium; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Fluoroquinolones; In Vitro Techniques; Levofloxacin; Limb Buds; Magnesium; Male; Mice; Mice, Inbred Strains; Ofloxacin; Piperazines; Pregnancy; Quinolones | 2002 |
[Intraocular penetration of topical lomefloxacin in rabbit's eyes].
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Eye; Female; Fluoroquinolones; Male; Permeability; Quinolones; Rabbits | 1998 |
Accumulation of ciprofloxacin and lomefloxacinin fluoroquinolone-resistant strains of Escherichia coli.
Topics: 2,4-Dinitrophenol; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Porins; Quinolones | 2002 |
Determination of lomefloxacin, an antibacterial drug, in pharmaceutical preparations based on its polarographic catalytic wave in the presence of 2-iodoacetamide.
Topics: Alkylating Agents; Anti-Infective Agents; Catalysis; Fluoroquinolones; Iodoacetamide; Pharmaceutical Preparations; Polarography; Quinolones | 2001 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
In vivo photochemical micronucleus induction due to certain quinolone antimicrobial agents in the skin of hairless mice.
Topics: Animals; Anti-Infective Agents; Chromosome Aberrations; Dose-Response Relationship, Drug; Fluoroquinolones; Levofloxacin; Light; Male; Mice; Mice, Hairless; Micronuclei, Chromosome-Defective; Micronucleus Tests; Ofloxacin; Photosensitizing Agents; Quinolones; Skin; Time Factors | 2002 |
Determination of lomefloxacin by terbium sensitized chemiluminescence method.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Kinetics; Luminescent Measurements; Quinolones; Sensitivity and Specificity; Spectrophotometry; Terbium; Time Factors | 2002 |
Genotoxicity of lomefloxacin--an antibacterial drug in somatic and germ cells of Swiss albino mice in vivo.
Topics: Animals; Anti-Infective Agents; Bone Marrow Cells; Chromosome Aberrations; Female; Fertility; Fluoroquinolones; Genes, Dominant; Genes, Lethal; Male; Mice; Mutagenicity Tests; Mutagens; Mutation; Ovum; Quinolones; Spermatozoa | 2003 |
[Study on photodegradation kinetics of lomefloxacin hydrochloride aqueous solution].
Topics: Anti-Infective Agents; Buffers; Decarboxylation; Fluoroquinolones; Hydrogen-Ion Concentration; Kinetics; Photochemistry; Quinolones; Solutions | 2001 |
Laser flash photolysis study of photoionization in fluoroquinolones.
Topics: Anti-Infective Agents; Electron Transport; Enoxacin; Fluoroquinolones; Lasers; Norfloxacin; Photochemistry; Photolysis; Photons; Quantum Theory; Quinolones; Solutions; Time Factors; Water | 2002 |
Reliability of phototoxic tests of fluoroquinolones in vitro.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Ciprofloxacin; Cricetinae; Cricetulus; Dermatitis, Phototoxic; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Micronucleus Tests; Norfloxacin; Quinolones; Rats; Rats, Wistar; Ultraviolet Rays | 2003 |
Effects of lomefloxacin and norfloxacin on pancreatic beta-cell ATP-sensitive K(+) channels.
Topics: Animals; Anti-Infective Agents; Cell Line; Dose-Response Relationship, Drug; Electrophysiology; Fluoroquinolones; Islets of Langerhans; Models, Chemical; Norfloxacin; Potassium Channels; Quinolinic Acid; Quinolones; Rats | 2003 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2003 |
Photocarcinogenesis in the Tg.AC mouse: lomefloxacin and 8-methoxypsoralen.
Topics: Animals; Animals, Genetically Modified; Carcinogenicity Tests; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Methoxsalen; Mice; Mice, Inbred Strains; Papilloma; Quinolones; Skin; Skin Neoplasms; Ultraviolet Rays | 2003 |
Molecular responses to photogenotoxic stress induced by the antibiotic lomefloxacin in human skin cells: from DNA damage to apoptosis.
Topics: Anti-Infective Agents; Apoptosis; Cells, Cultured; DNA Damage; Fibroblasts; Fluoroquinolones; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Keratinocytes; Melanocytes; Membrane Proteins; Photosensitizing Agents; Quinolones; Skin; Skin Pigmentation; Tumor Suppressor Protein p53; Ultraviolet Rays | 2003 |
[Study on the direct determination of lomefloxacin in urine by derivative-synchronous fluorescence].
Topics: Anti-Infective Agents, Urinary; Fluoroquinolones; Quinolones; Sensitivity and Specificity; Spectrometry, Fluorescence | 2002 |
Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
Topics: Binding Sites; Chloroquine; Ciprofloxacin; Drug Interactions; Enoxacin; Fluoroquinolones; Levodopa; Levofloxacin; Melanins; Monophenol Monooxygenase; Norfloxacin; Ofloxacin; Quinolones; Timolol | 2003 |
Aqueous humor levels of topically applied levofloxacin, norfloxacin, and lomefloxacin in the same human eyes.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Aqueous Humor; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Norfloxacin; Ofloxacin; Quinolones | 2003 |
[Levofloxacin (Tavanic) in the treatment of corneal ulcers].
Topics: Administration, Oral; Anti-Infective Agents; Corneal Ulcer; Drug Administration Schedule; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Ofloxacin; Ophthalmic Solutions; Quinolones; Treatment Outcome | 2003 |
[Analysis of the response factors of different quinolones detected by evaporative light-scattering detector].
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Light; Linear Models; Ofloxacin; Quinolones | 2003 |
Compare two methods of measuring DNA damage induced by photogenotoxicity of fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Comet Assay; Cricetinae; Cricetulus; DNA; DNA Damage; Fibroblasts; Fluoroquinolones; Levofloxacin; Ofloxacin; Quinolones; Ultraviolet Rays | 2004 |
[Simultaneous determination of quinolones in foods by LC/MS/MS].
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fishes; Fluoroquinolones; Food Analysis; Meat; Ofloxacin; Quinolones; Spectrometry, Mass, Electrospray Ionization | 2004 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
[Antimicrobial susceptibility surveillance of recent isolates from ophthalmological infections to gatifloxacin and other antimicrobial drugs].
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Quinolones | 2005 |
[Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].
Topics: Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Liver; Lung; Mice; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2005 |
In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Topics: Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Quinolones; Sampling Studies; Sensitivity and Specificity | 2005 |
The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.
Topics: Anti-Bacterial Agents; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Industry; Drug Stability; Fluoroquinolones; Hydrogen-Ion Concentration; Models, Chemical; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Reproducibility of Results; Tablets; Time Factors | 2005 |
Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Chronic Disease; Fluoroquinolones; Humans; Levofloxacin; Male; Ofloxacin; Prostatitis; Quinolones | 2005 |
Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibiotics in pharmaceutical preparations by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ethylamines; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Levofloxacin; Models, Chemical; Models, Statistical; Ofloxacin; Pefloxacin; Pharmaceutical Preparations; Quinolones; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets; Temperature; Time Factors | 2006 |
The photocarcinogenesis of antibiotic lomefloxacin and UVA radiation is enhanced in xeroderma pigmentosum group A gene-deficient mice.
Topics: Animals; Anti-Bacterial Agents; Carcinogens; DNA Damage; DNA-Binding Proteins; Fluoroquinolones; Mice; Mice, Mutant Strains; Mutation; Neoplasms, Radiation-Induced; Photosensitizing Agents; Pyrimidine Dimers; Quinolones; Skin Neoplasms; Ultraviolet Rays; Xeroderma Pigmentosum Group A Protein | 2005 |
Electrochemical adsorptive behavior of some fluoroquinolones at carbon paste electrode.
Topics: Adsorption; Anti-Infective Agents; Carbon; Chromatography, High Pressure Liquid; Electrochemistry; Electrodes; Fluoroquinolones; Gatifloxacin; Quinolones | 2005 |
Antimicrobial activity of a new difluorinated quinolone: lomefloxacin (SC-47111).
Topics: Anti-Infective Agents; Citrobacter freundii; Enterobacter cloacae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Proteus; Quinolones | 1989 |
In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones | 1989 |
Microbiological studies on lomefloxacin--a new quinolone.
Topics: Acinetobacter; Anti-Infective Agents; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas; Quinolones; Staphylococcus | 1989 |
Preliminary results on the antibacterial and killing activity of lomefloxacin.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Staphylococcus | 1989 |
In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
Topics: Anti-Infective Agents; Bacterial Infections; Enterobacteriaceae; Enterococcus; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Staphylococcus | 1989 |
In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacteria; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Urinary Tract Infections | 1989 |
Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
Topics: Anti-Bacterial Agents; Bacterial Infections; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quinolones | 1989 |
Spectrofluorimetric study on the inclusion interaction between lomefloxacin and p-sulfonated calix[4]arene and its analytical application.
Topics: Calixarenes; Fluoroquinolones; Phenols; Quinolones; Spectrometry, Fluorescence; Sulfonic Acids | 2006 |
In vitro availability of lomefloxacin hydrochloride in presence of essential and trace elements.
Topics: Anti-Bacterial Agents; Biological Availability; Drug Interactions; Fluoroquinolones; Quinolones; Structure-Activity Relationship; Trace Elements | 2005 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Spectrofluorimetric determination of trace heparin using lomefloxacin-terbium probe.
Topics: Fluorescent Dyes; Fluoroquinolones; Heparin; Humans; Hydrogen-Ion Concentration; Injections; Quinolones; Spectrometry, Fluorescence; Terbium; Time Factors | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cornea; Female; Fluoroquinolones; Humans; Keratoplasty, Penetrating; Levofloxacin; Male; Middle Aged; Norfloxacin; Ofloxacin; Quinolones; Tissue Distribution | 2006 |
Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice.
Topics: Animals; Blood Glucose; Enoxacin; Fluoroquinolones; Gatifloxacin; Hypoglycemia; Male; Mice; Quinolones | 2006 |
Chiral separation of four fluoroquinolone compounds using capillary electrophoresis with hydroxypropyl-beta-cyclodextrin as chiral selector.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Electrophoresis, Capillary; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Molecular Structure; Ofloxacin; Oxazines; Quinolones; Stereoisomerism | 2006 |
Photo-chemically induced DNA effects in the comet assay with epidermal cells of SKH-1 mice after a single oral administration of different fluoroquinolones and 8-methoxypsoralen in combination with exposure to UVA.
Topics: Administration, Oral; Animals; Cells, Cultured; Ciprofloxacin; Comet Assay; DNA; DNA Damage; Epidermal Cells; Epidermis; Fluoroquinolones; Male; Methoxsalen; Mice; Mice, Hairless; Quinolones; Ultraviolet Rays | 2006 |
[Synchronous fluorimetric determination of the residues of three quinolones in Eel by partial least squares].
Topics: Animals; Anti-Bacterial Agents; Drug Residues; Eels; Fluorometry; Fluoroquinolones; Least-Squares Analysis; Levofloxacin; Norfloxacin; Ofloxacin; Quinolones; Seafood | 2006 |
Broad-spectrum sunscreens prevent the secretion of proinflammatory cytokines in human keratinocytes exposed to ultraviolet A and phototoxic lomefloxacin.
Topics: Cell Survival; Cells, Cultured; Cytokines; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluoroquinolones; Humans; Inflammation Mediators; Keratinocytes; Quinolones; Sunscreening Agents; Ultraviolet Rays | 2006 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Enhanced separation of seven quinolones by capillary electrophoresis with silica nanoparticles as additive.
Topics: Buffers; Electrophoresis, Capillary; Fleroxacin; Fluoroquinolones; Gatifloxacin; Nanoparticles; Ofloxacin; Oxazines; Quinolones; Silicon Dioxide | 2009 |
Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection.
Topics: Anti-Bacterial Agents; Aza Compounds; Calibration; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluorescence; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Reproducibility of Results | 2009 |
[Preliminary study on occurrence and health risk assessment of quinolone antibiotics in vegetables from Guangzhou, China].
Topics: Anti-Bacterial Agents; China; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Quinolones; Risk Assessment; Urban Health; Vegetables | 2010 |
Spectroscopic study of degradation products of ciprofloxacin, norfloxacin and lomefloxacin formed in ozonated wastewater.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Mass Spectrometry; Norfloxacin; Oxidation-Reduction; Ozone; Piperazine; Piperazines; Quinolones; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2012 |
Determination of five quinolone antibiotic residues in foods by micellar electrokinetic capillary chromatography with quantum dot indirect laser-induced fluorescence.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Cadmium Compounds; Chromatography, Micellar Electrokinetic Capillary; Ciprofloxacin; Enrofloxacin; European Union; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Japan; Lasers; Limit of Detection; Loxapine; Norfloxacin; Quantum Dots; Quinolones; Spectrometry, Fluorescence; Tellurium | 2014 |
Changes in the Oxidation-Reduction State of Human Dermal Fibroblasts as an Effect of Lomefloxacin Phototoxic Action.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antioxidants; Dermatitis, Phototoxic; Fibroblasts; Fluoroquinolones; Humans; Oxidation-Reduction; Quinolones; Reactive Oxygen Species | 2022 |